US 7,828,810 B2Grant
Apparatus and method for the ligation of tissue
Issue Date:2010-11-09
•15 Claims
•33 Drawing Sheets
Abstract
A novel catheter-based system which ligates the left atrial appendage (LAA) on the outside of the heart, preferably using a combination of catheters and/or instruments, e.g., a guide catheter positioned inside the left atrial appendage which may assist in locating the left atrial appendage and/or assist in the optimal placement of a ligature on the outside of the appendage, and a ligating catheter and/or instrument outside the heart in the pericardial space to set a ligating element at the neck of the left atrial appendage.
Metadata
Assignee
- SentreHEART, Inc.
Inventors
- John R. Liddicoat
- William E. Cohn
- Roger Laham
Application Information
Application Number:US 11/600,671
Filing Date:2006-11-15
Priority Date:2003-10-09
Art Unit:3731
Classifications
IPC:
A61B17/10
Patent Drawings (33 sheets)
Description
RELATED APPLICATIONS
[0001] This is a continuation of U.S. application Ser. No. 10/963,371, filed Oct. 11, 2004, which claims the benefit of U.S. Provisional Patent Application Ser. Nos. 60/510,100, filed Oct. 9, 2003, and 60/528,995, filed Dec. 12, 2003. The entire content of each application is incorporated herein by reference in their entirety.
FIELD OF THE INVENTION
[0002] This invention relates to apparatus and methods for ligating tissue, and more particularly to ligating cardiac tissue, and even more particularly to ligating tissue of the left atrium. In one preferred form of the present invention, ligation of the left atrial appendage is effected using a novel apparatus and method.
BACKGROUND OF THE INVENTION
[0003] Atrial fibrillation is a common problem that afflicts millions of patients. Unfortuately, atrial fibrillation often results in the formation of a thrombus, or clot, in the appendage of the left atrium. This presents a problem, inasmuch as the thrombus can dislodge and embolize to distant organs, resulting in adverse events such as a stroke. For this reason, most patients with atrial fibrillation are treated with a blood thinner so as to help prevent the formation of a thrombus in the left atrial appendage. Unfortunately, blood thinners pose a substantial health risk in their own right, particularly in the elderly.
[0004] An alternative treatment for atrial fibrillation is the ligation of the atrial appendage at its base. This procedure occludes the space in which the thrombus can form, thereby substantially eliminating the risk of forming a clot in the left atrial appendage and/or preventing a clot in the appendage from embolizing. Surgeons have been ligating atrial appendages for years during open surgical procedures. Though effective, this approach requires general anesthesia and surgically opening the chest, which presents additional serious health risks to the patient. Therefore, such open-chest ligation of the atrial appendage is normally restricted to situations where the chest is already being surgically opened for other reasons, or where the patient is at a particularly high risk of embolizing.
[0005] Recently, catheter-based techniques have been developed for occluding the left atrial appendage space by placing mechanical devices inside the left atrial appendage. This is done under fluoroscopic and/or echocardiographic guidance without the need for a major chest incision or general anesthesia. Unfortunately, however, these techniques require the implantation of mechanical intracardiac devices which, over time, may result in clot formation, incomplete occluding of the appendage space, infection, etc.
SUMMARY OF THE INVENTION
[0006] These and other issues are addressed by the present invention, which comprises a novel catheter-based system which ligates the left atrial appendage (LAA) on the outside of the heart, preferably using a combination of catheters and/or instruments, e.g., a guide catheter positioned inside the left atrial appendage which may assist in locating the left atrial appendage and/or assist in the optimal placement of a ligature on the outside of the appendage, and a ligating catheter and/or instrument outside the heart in the pericardial space to set a ligating element at the neck of the left atrial appendage. As a result, this novel approach provides the advantages of both the open surgical approach (i.e., successful ligation of the atrial appendage on the outside of the heart, while avoiding implantation of a mechanical intracardiac device within the heart), and the catheter-based approach (i.e., providing rapid and reliable access to the left atrial appendage without the need for a major chest incision or general anesthesia).
[0007] The apparatus and method described herein are primarily intended to ligate the left atrial appendage, however, the apparatus and method may also be used in the same or similar constructions to stabilize, suture, and/or ligate any other tissue in the body. By way of example but not limitation, using the apparatus and method described herein, other tissues of the heart (such as the left ventricle) may be manipulated so as to alter the conformational geometry of the heart into a more favorable shape.
[0008] In another form of the invention, there is provided a guide catheter for use in conjunction with a ligating catheter for ligating tissue, comprising:
[0009] a shaft having a distal end; and
[0010] an alignment element disposed on the distal end of the shaft, wherein the alignment element interacts with a counterpart alignment element on the ligating catheter so as to facilitate alignment of the ligating catheter with the guide catheter.
[0011] In another form of the invention, there is provided a guide catheter for use in conjunction with a ligating catheter for ligating tissue, comprising:
[0012] a shaft having a distal end; and
[0013] an expandable element connected to the distal end of the shaft, wherein the expandable element is configured to expand to a size corresponding to the interior of the left atrial appendage.
[0014] In another form of the invention, there is provided a ligating catheter for ligating tissue, comprising:
[0015] a hollow shaft having a distal end;
[0016] a ligating subassembly comprising a plurality of expandable arms arranged in an arcuate configuration and releasably supporting a ligating element thereon, the ligating subassembly being slidably received within the hollow shaft and adapted to move between (i) a retracted position wherein the expandable arms are received within the hollow shaft, and (ii) an extended position wherein the expandable arms project from the distal end of the hollow shaft, with the expandable arms holding the ligating element radially outboard of the shaft when the ligating subassembly is in its second position.
[0017] In another form of the invention, there is provided a ligating catheter for ligating tissue, comprising:
[0018] a hollow shaft having a distal end;
[0019] a ligating subassembly comprising a plurality of expandable arms arranged in an arcuate configuration and releasably supporting a ligating element thereon, the ligating subassembly being slidably received within the hollow shaft and adapted to move between (i) a retracted position wherein the expandable arms are received within the hollow shaft, and (ii) an extended position wherein the expandable arms project from the distal end of the hollow shaft, with the expandable arms holding the ligating element radially outboard of the shaft when the ligating subassembly is in its second position;
[0020] an alignment element mounted to the shaft, wherein the alignment element interacts with a counterpart alignment element on a guide catheter disposed within the tissue to be ligated; and
[0021] gripping apparatus for gripping tissue, wherein the gripping apparatus comprises a suction tube mounted to the hollow shaft.
[0022] In another form of the invention, there is provided a system for ligating tissue comprising:
[0023] a guide catheter comprising:
[0024] a shaft having a distal end; and
[0025] an alignment element disposed on the distal end of the shaft, wherein the alignment element interacts with a counterpart alignment element on a ligating catheter so as to facilitate alignment of the ligating catheter with the guide catheter; and
[0026] a ligating catheter for ligating tissue, comprising:
[0027] a hollow shaft having a distal end;
[0028] a ligating subassembly comprising a plurality of expandable arms arranged in an arcuate configuration and releasably supporting a ligating element thereon, the ligating subassembly being slidably received within the hollow shaft and adapted to move between (i) a retracted position wherein the expandable arms are received within the hollow shaft, and (ii) an extended position wherein the expandable arms project from the distal end of the hollow shaft, with the expandable arms holding the ligating element radially outboard of the shaft when the ligating subassembly is in its second position; and
[0029] an alignment element mounted to the shaft, wherein the alignment element interacts with counterpart alignment element on the guide catheter when the guide catheter is disposed within the tissue to be ligated.
[0030] In another form of the invention, there is provided a system for ligating tissue comprising:
[0031] a guide catheter comprising:
[0032] a shaft having a distal end; and
[0033] an alignment element disposed on the distal end of the shaft, wherein the alignment element interacts with a counterpart alignment element on a ligating catheter so as to facilitate alignment of the ligating catheter with the guide catheter; and
[0034] an expandable element connected to the distal end of the shaft, wherein the expandable element is configured to expand to a size corresponding to the interior of the left atrial appendage; and
[0035] a ligating catheter for ligating tissue, comprising:
[0036] a hollow shaft having a distal end;
[0037] a ligating subassembly comprising a plurality of expandable arms arranged in arcuate configuration and releasably supporting a ligating element thereon, the ligating subassembly being slidably received within the hollow shaft and adapted to move between (i) a retracted position wherein the expandable arms are received within the hollow shaft, and (ii) an extended position wherein the expandable arms project from the distal end of the hollow shaft, with the expandable arms holding the ligating element radially outboard of the shaft when the ligating subassembly is in its second position;
[0038] an alignment element mounted to the shaft, wherein the alignment element interacts with counterpart alignment element on the guide catheter when the guide catheter is disposed within the tissue to be ligated; and
[0039] a gripping apparatus for gripping tissue, wherein the gripping apparatus comprises a suction tube mounted to the hollow shaft.
[0040] In another form of the invention, there is provided a method for ligating tissue, comprising:
[0041] positioning a guide catheter within the interior of the tissue to be ligated, wherein the guide catheter comprises an alignment element for interacting with a counterpart alignment element on a ligating catheter;
[0042] advancing a ligating catheter so as to position a ligating element about the tissue to be ligated, wherein the ligating catheter interacts with the alignment element on the guide catheter when positioning the ligating element about the tissue to be sutured; and
[0043] contracting the ligating element about the tissue, whereby to ligate the tissue.
[0044] In another form of the invention, there is provided a method for ligating tissue, comprising:
[0045] providing a guide catheter and a ligating catheter, wherein the guide catheter comprises an alignment element for interacting with a counterpart aligning element on the ligating catheter so as to facilitate alignment of the ligating catheter with the guide catheter;
[0046] positioning the guide catheter within the tissue to be ligated;
[0047] using the alignment elements to align the ligating catheter with the guide catheter and about the tissue to be ligated; and
[0048] ligating the tissue with the ligating catheter.
[0049] In another form of the invention, there is provided a system for ligating tissue comprising:
[0050] a wire extending from the interior of the left atrial appendage, through the side wall of the left atrial appendage, and out the pericardium;
[0051] a guide catheter slidably mounted on the wire, comprising:
[0052] a shaft having a distal end; and
[0053] an expandable element connected to the distal end of the shaft, wherein the expandable element is configured to expand to a size corresponding to the interior of the left atrial appendage; and
[0054] a ligating catheter for ligating tissue, comprising:
[0055] a hollow shaft having a distal end; and
[0056] a ligating subassembly comprising a plurality of expandable arms arranged in an arcuate configuration and releasably supporting a ligating element thereon, the ligating subassembly being slidably received within the hollow shaft and adapted to move between (i) a retracted position wherein the expandable arms are received within the hollow shaft, and (ii) an extended position wherein the expandable arms project from the distal end of the hollow shaft, with the expandable arms holding the ligating element radially outboard of the shaft when the ligating subassembly is in its second position.
[0057] In another form of the invention, there is provided a method for performing a procedure on a body structure, comprising:
[0058] inserting a first device with an alignment element into the body structure;
[0059] positioning a second device outside of the body structure;
[0060] aligning the first device with the second device with the alignment element; and
[0061] performing a procedure on the body structure with the devices.
BRIEF DESCRIPTION OF THE DRAWINGS
[0062] These and other objects and features of the present invention will be more fully disclosed or rendered obvious by the following detailed description of the preferred embodiments of the invention, which are to be considered together with the accompanying drawings wherein like numbers refer to like parts.
[0063] FIG. 1 is a side view of a ligating catheter, with the catheter's ligation subassembly being disposed in a retracted position.
[0064] FIG. 2 is a view like that of FIG. 1 , except that portions of the ligating catheter have been shown in phantom.
[0065] FIG. 3 is an end view of the ligating catheter shown in FIG. 1 .
[0066] FIG. 4 is a view like that of FIG. 1 , except that the catheter's ligation subassembly is shown in an extended position.
[0067] FIG. 5 is a view like that of FIG. 4 , except that portions of the ligating catheter have been shown in phantom.
[0068] FIG. 6 is an end view of the ligating catheter shown in FIG. 4 .
[0069] FIG. 7 is a view like that of FIG. 4 , but with the ligating element being contracted.
[0070] FIG. 8 is an end view of the ligating catheter shown in FIG. 7 .
[0071] FIG. 9 is a view like that of FIG. 7 , but with the catheter's ligation subassembly fully retracted.
[0072] FIG. 10 is a view like that of FIG. 9 , except that certain portions of the ligating catheter are shown in phantom.
[0073] FIG. 11 is a view like that of FIG. 10 , except that the ligating element has been severed from the ligating catheter.
[0074] FIG. 12 is a side view showing the ligating catheter in combination with a guide catheter.
[0075] FIG. 13 is a side view of the distal tip of the guide catheter, with the catheter's expanding element being shown in a contracted position.
[0076] FIG. 14 is a view like that of FIG. 13 , except that the catheter's expanding element is shown in an expanded position.
[0077] FIG. 15 is a view showing the distal tip of the guide catheter placed within the left atrial appendage, with the catheter's expanding element being shown in a contracted position.
[0078] FIG. 16 is a view like that of FIG. 15 , except that the catheter's expanding element is shown in an expanded position.
[0079] FIG. 17 shows the guide catheter placed within the left atrial appendage, the guide catheter's expanding element placed in its expanded state, and the ligating catheter placed over the left atrial appendage.
[0080] FIG. 18 is a view like that of FIG. 17 , except that the ligating catheter has had its ligating element contracted about the neck of the left atrial appendage.
[0081] FIG. 19 is a view like that of FIG. 18 , except that the ligating catheter has been withdrawn from the surgical site.
[0082] FIG. 20 is a view like that of FIG. 19 , except that the guide catheter's expanding element has been contracted.
[0083] FIG. 21 is a view like that of FIG. 20 , except that the guide catheter has been withdrawn from the left atrial appendage.
[0084] FIG. 22 is a schematic view showing the distal end of the guide catheter.
[0085] FIG. 23 is a schematic view showing the guide catheter's balloon in an expanded condition.
[0086] FIG. 24 is a schematic view showing the ligating catheter and the guide catheter.
[0087] FIG. 25 is a schematic view showing the distal end of the ligating catheter.
[0088] FIGS. 26 and 27 are schematic views showing the distal ends of the ligating catheter and the guide catheter orienting an end-to-end fashion through the use of magnets.
[0089] FIG. 28 is a schematic view showing a flared suction tube extending out of the ligating catheter's outer tube.
[0090] FIG. 29 is a schematic view showing details of the ligating subassembly.
[0091] FIG. 30 is a schematic view showing the ligating subassembly extending over the guide catheter's inflated balloon.
[0092] FIG. 31 is a schematic view showing the ligature being drawn taut on the outboard side of the guide catheter's balloon.
[0093] FIG. 32 is a schematic view showing a single wire track passing from the interior of the left atrial appendage out through the pericardium, whereby a guide catheter and/or a ligating catheter may be advanced to the surgical site.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
Ligating Catheter
[0094] Looking first at FIG. 1 , there is shown a ligating catheter 2 formed in accordance with the present invention. Ligating catheter 2 comprises an elongated tube or cylinder 5, having a distal end 10 and a proximal end 15. Exiting from proximal end 15 are one or more advancement/retraction control elements 20, which are connected to the ligation subassembly (not shown in FIG. 1 ) disposed inside cylinder 5. In the construction shown in FIG. 1 , advancement/retraction control elements 20 comprise cables or wires. One or more advancement/retraction control elements 20 are used to advance or withdraw the ligation subassembly (not shown in FIG. 1 ) disposed inside cylinder 5. In addition to the foregoing, one or more constriction control elements 25 also exit from the proximal end of cylinder 5. Constriction control elements 25 are also connected to the ligation subassembly (not shown in FIG. 1 ) disposed inside cylinder 5 and are used to tighten or loosen the ligating element (also not shown in FIG. 1 ) about a portion of the tissue or the like. In the construction shown in FIG. 1 , constriction control elements 25 comprise cables or sutures.
[0095] Looking next at FIG. 2 , outer cylinder 5 is shown in phantom. FIG. 2 shows the ligation subassembly 30 in an undeployed state, i.e., with ligation subassembly 30 retracted into cylinder 5. Inside cylinder 5, ligation subassembly 30 is shown having a ligating element 32 (e.g., a suture or string) that may be connected to supports or guides (such as felt pledgets or loops 35) which help to grip and protect the tissue which is being ligated. Ligation subassembly 30 also includes supporting structure 40 with struts 45. Felt pledgets 35 are disposed on the distal ends of struts 45. Struts 45 are configured to expand when ligation subassembly 30 is deployed from cylinder 5. In one preferred construction, struts 45 are expanded by connecting them to one another with springs 50, whereby to render struts 45 self-expandable when the struts are advanced out of the distal end of cylinder 5. Ligation subassembly 30 is connected to advancement/retraction control elements 20, whereby the ligation subassembly 30 can be advanced out of, or retracted into, cylinder 5. Furthermore, ligation subassembly 30 is connected to constriction control elements 25, whereby the ligating element 32 can be constricted about a piece of tissue or the like. Advancement/retraction control elements 20, and/or constriction control elements 25, may be connected to an appropriate handle (not shown) for manipulation by a practitioner.
[0096] Looking now at FIG. 3 , there is shown the distal end 10 of cylinder 5, with the ligation subassembly 30 undeployed within outer cylinder 5, with felt pledgets 35.
[0097] Looking next at FIG. 4 , a portion of the ligation subassembly 30 is shown advanced out the distal end of the cylinder 5. The ligation subassembly 30 expands as the struts 45 exit the constraining environment of tube 5 and expand away from one another. In the construction shown in FIGS. 1-4 , struts 45 expand under the influence of springs 50. Ligation subassembly 30 is connected to constriction control elements 25 which extend beyond proximal end 15 of tube 5 for actuation by the practitioner. Ligation subassembly 30 may be advanced out of the cylinder by pushing on advancement/retraction control elements 20.
[0098] FIG. 5 is similar to FIG. 4 , except that the walls of cylinder 5 are shown in phantom, thereby exposing the inner workings of the device. Struts 45 are shown connected to supporting structure 40, e.g., an inner supporting ring 40.
[0099] FIG. 6 is a distal end view of the device, showing ligation subassembly 30 advanced out of cylinder 5. Ligation subassembly 30 is expanded radially, with the ligating element 32 following an expanded arcuate path about the distal ends of struts 45, with the proximal ends of ligating element 32 passing up through the center of cylinder 5 for actuation by constriction control elements 25. Thus, ligating element 32 is supported by struts 45 (or other means), struts 45 may be expanded by springs 50 (or by other means), and struts 45 may be supported by supporting structure 40.
[0100] Looking next at FIG. 7 , ligating catheter 2 is shown with ligating element 32 contracted. Ligating element 32 may be contracted by pulling on the proximal ends of constriction control elements 25. This actuation causes radial contraction of the ligature loop.
[0101] FIG. 8 is a distal end view of the ligating catheter 2 with ligating element 32 contracted. There is radial compression of the ligature loop. Preferably, the inner supporting structure 40 remains unchanged in radial dimension, as does the distal end of the cylinder 5. Preferably, struts 45 and springs 50 collapse as the device is actuated by the practitioner.
[0102] FIG. 9 shows struts 45 and springs 50 retracted back into cylinder 5, i.e., by pulling on the advancement/retraction control elements 20. Ligating element 32 remains in place, applying radial compression to any captivated tissue.
[0103] FIG. 10 is similar to FIG. 9 , except that ligating catheter 2 is shown with its cylinder 5 in phantom. Struts 45, springs 50, and supporting structure 40 are shown retracted into cylinder 5.
[0104] FIG. 11 shows the ligating element 32 severed from constriction control elements 25.
Guide Catheter
[0105] FIG. 12 shows the ligating catheter 2 equipped with an alignment element 90. Alignment element 90 is intended for use in aligning ligating catheter 2 with a left atrial appendage or other target structure. In one embodiment of the present invention, alignment element 90 comprises a radio-opaque material and the device is placed into the desired anatomical position by visualization, e.g., fluoroscopy.
[0106] Alternatively, and more preferably, alignment element 90 is intended to work in conjunction with a guide catheter 100, wherein the guide catheter 100 is placed (e.g., endoluminally) within the interior of the left atrial appendage. In this construction, guide catheter 100 also comprises a radio-opaque material, and alignment element 90 and guide catheter 100 are placed in alignment by visualization.
[0107] Even more preferably, ligating catheter 2 and guide catheter 100 are provided with physical means (e.g., magnets, male and female connectors, wires and snares, etc.) to facilitate alignment of ligating catheter 2 and guide catheter 100. Thus, in one preferred construction, ligating catheter 2 has its alignment element 90 equipped with a reference magnet 95 at its distal tip. Guide catheter 100 in turn comprises an alignment element 102 having a reference magnet 105 at its distal tip. More particularly, with this preferred construction, ligating catheter 2 has the alignment element 90 which can be extended from the distal end of cylinder 5. On the distal end of alignment element 90 is the reference magnet 95. Alignment element 90 is put into proximity with the guide catheter 100, which has the alignment element 102 with reference magnet 105 mounted on its distal end. When these two alignment elements 90 and 102 are brought into proximity with one another, magnets 95 and 105 cause the alignment elements 90 and 102 to automatically align with one another.
[0108] For example, during left atrial appendage ligation, guide catheter 100 is passed endoluminally into the left atrium appendage under visual guidance such as fluoroscopy or ultrasound. The ligating catheter 2 is passed into the pericardium. The alignment element 90 of the ligating catheter is then extended from cylinder 5. Once alignment element 90 is placed into proximity with alignment element 102, magnets 95, 105 cause the two catheters to automatically align with one another, thereby causing ligating catheter 2 to assume a desired position with respect to the left atrial appendage. Then, ligating catheter 2 is utilized as described above to ligate the left atrial appendage.
[0109] Looking next at FIG. 13 , there is shown a guide catheter 100 which is provided with an expandable element 115. Expandable element 115 is adapted to expand inside the anatomy (e.g., the left atrial appendage) so as to facilitate ligation. As noted above, guide catheter 100 has a magnet 105 mounted to its distal end. It should be noted that expandable element 115 is shown in its non-expanded state in FIG. 13 .
[0110] Looking next at FIG. 14 , guide catheter 100 is shown with its expandable element 115 in its expanded state.
[0111] FIG. 15 shows guide catheter 100, with its expandable element 115 not expanded, and with guide catheter 100 disposed in the left atrial appendage 130.
[0112] FIG. 16 shows guide catheter 100, with its expandable element 115 expanded, and with guide catheter 100 shown in the left atrial appendage 130. In this respect it should be appreciated when expandable element 115 is in its expanded condition within left atrial appendage 130, expandable element 115 may or may not alter the shape of the recipient tissue, depending on the size of the tissue cavity, the size of the expanded expandable element 115, etc.
Ligating Catheter Used in Conjunction with Guide Catheter
[0113] FIG. 17 shows guide catheter 100 with its expandable element 115 expanded in the left atrial appendage 130, and with ligating catheter 2 expanded over the left atrial appendage 130. This aligned positioning is facilitated through the use of alignment element 90 on ligating catheter 2 and alignment element 102 on guide catheter 100. More particularly, guide catheter 100 is positioned in the left atrial appendage 130, expandable element 115 is expanded, ligating catheter 2 is positioned in the state depicted in FIGS. 4 , 5 and 6 and, using guide elements 90 and 102 to align the apparatus, ligating catheter 2 is slid over the left atrial appendage 130. Guide catheter 100 (inside the left atrial appendage) and ligating catheter 2 are aligned in this preferred construction using magnets 120 and 95, respectively. Significantly, by properly sizing the apparatus vis-à-vis the anatomy, ligating element 32 can be positioned at the neck of the left atrial appendage (and on the atrium side of expandable element 115) when alignment elements 90 and 102 function as described.
[0114] Looking next at FIG. 18 , guide catheter 100 is shown in the left atrial appendage 130, with its expandable element 115 in its expanded condition, and ligating catheter 2 is shown actuated as described hereinabove with respect to FIGS. 7 and 8 . Due to the relative positioning of the expanded guide catheter 100 within the left atrial appendage 130 while ligating catheter 2 is being actuated, the constricting ligating element 32 is maintained at the neck of the left atrial appendage 130 by the presence of the expandable element 115, thereby helping to ensure proper positioning of the ligating element 32 relative to the anatomy. In other words, the presence of the expandable element 115 inside the left atrial appendage 130 guides ligature 32 into the desired position 135. In the example of ligating the left atrial appendage 130, the desired position 135 is where the left atrial appendage 130 meets the left atrium 140.
[0115] Looking next at FIG. 19 , the apparatus is shown with guide catheter 100 still in the left atrial appendage 130, but with the ligating catheter 2 withdrawn, leaving the ligating element 32 deployed at the neck of the left atrial appendage 130.
[0116] In FIG. 20 , guide catheter 100 has had its expandable element 115 returned to its unexpanded condition.
[0117] Looking next at FIG. 21 , the left atrial appendage 130 is shown with guide catheter 100 removed from the interior of the left atrial appendage, leaving ligating element 32 at the location where the left atrial appendage 130 meets the left atrium 140, thereby effectively ligating the left atrial appendage from atrium 140.
One Preferred Form of Use
[0118] In one preferred form of use, guide catheter 100 is passed endoluminally across the atrial septum and into the left atrium. Guide catheter 100 (FIG. 22 ) has one or more magnets 105 at its tip. Magnets 105 are preferably so-called “rare earth” magnets composed of, for example, Neodymium-Iron-Boron,
[0119] Cobalt-Samarium or other powerful fixed magnet elements. Just behind the magnets, preferably integral with and axi-symmetric to the body of the guide catheter, is inflatable balloon 115 (FIG. 23 ) which, when inflated, is spherical, conical, elliptical or of other configuration, and which preferably conforms roughly to the size and shape of the left atrial appendage 130. The entire guide catheter 100, inclusive of balloon 115 and magnets 105, is of a size consistent with passage through a commercially-available sheath (not shown), the likes of which may be readily passed across the atrial septum under fluoroscopic guidance using currently available tools and techniques.
[0120] In one preferred use of this system, the practitioner gains percutaneous access to the femoral vein using the Seldinger or other standard technique, and the aforementioned sheath (not shown) is introduced under fluoroscopic guidance across the atrial septum. The magnetic tip 105 of the guide catheter is then advanced out of the aforementioned sheath and into the left atrial appendage, in the manner previously discussed.
[0121] The second instrument used with this iteration (i.e., the ligating catheter 2, as shown in FIG. 24 ) is introduced into the pericardial space, between the heart and the pericardium. Pericardial access may be obtained, for example, by either a small incision below the zyphoid process of the sternum, or by percutaneous access using needles or dedicated systems designed for such purposes. Under fluoroscopic guidance, a wire is introduced into the pericardial space, between the heart and the pericardial sack. Similarly, pericardial access can be obtained by way of a mini-thoracotomy or by a “Chamberlain”-type incision over the 2nd costal cartilage. Percutaneous access using dedicated systems designed for such purposes is generally preferred as it can be done under local anesthesia. An incision over the 2nd costal cartilage, or a small incision below the zyphoid, is generally preferred to approaches that require violation of the left pleural space.
[0122] Once pericardial access is obtained, the second instrument (i.e., the ligating catheter 2, as shown in FIG. 25 ) is introduced to the surgical site. In a preferred embodiment, the second instrument is preceded by a series of dilators and sheaths that are introduced over wires. The dilators are of a progressively increasing size culminating in the placement of a large thin-walled tube or cylinder 5, approximately 24 French or smaller, positioned such that its distal end is in the region of the left atrial appendage. This thin-walled tube 5 then acts as a delivery cannula for advancing the ligating subassembly 30 to the surgical site. In one iteration, the distal end 10 of the thin-walled tube 5 is deflectable by an asymmetric element that can be placed under tension. Alternatively, the thin-walled tube may have a permanent angulation or curve at its tip.
[0123] Once the thin-walled tube 5 is in position, the intrapericardial tool (i.e., the ligating subassembly 30) is advanced down the thin-walled tube 5. In a preferred embodiment, the ligating catheter 2 comprises a central intrapericardial catheter or alignment element 90 at the end of which is one or more rare-earth magnets 95, as described previously. These magnets 95 are poled to attract the ligating catheter 2 to the guide catheter 100 (previously placed in the left atrial appendage) in an end-to-end orientation. The ligating catheter 2 may be flexible or, in another embodiment, is stiff with a malleable, deflectable tip.
[0124] Coaxial to this alignment element 90, and constructed in such a manner that it can be advanced or withdrawn relative to either the alignment element 90 or the thin-walled tube 5, is a tube 150 that ends in a funnel-like or trumpet-bell flare 160. The internal diameter of this flared tube 150 is significantly larger than the external diameter of the intrapericardial magnet-tipped alignment element 90 (over which the flared tube 150 slides) so as to allow vacuum to be conveyed from the back of the flared tube 150 to the distal flare 160. This flared end 160 acts as a suction cup to grasp the tip of the left atrial appendage 130 from outside the heart.
[0125] In a preferred embodiment, the ligating catheter's alignment element 90 is advanced (FIG. 26 ) under fluoroscopic guidance until it engages, and couples with, the guide catheter 100 (FIG. 27 ), which was previously placed across the atrial septum and into the inside of the left atrial appendage. Once such alignment has been achieved, and magnetic coupling confirmed by fluoroscopy, the flared tube 150 is advanced (FIG. 28 ) until it comes into contact with the outside of the left atrial appendage. Suction is then applied to the back of the flared tube 150, such that the left atrial appendage is fixed to the tip of the flared tube by vacuum.
[0126] Over the outside of this flared tube 150, but inside the lumen of the 24 French thin-walled tube 5, is a Nitinol stent-like structure or ligation subassembly 30 that can be advanced down the thin-walled tube 5 toward the tissue by way of a stiff catheter or other structure (i.e., the advancement/retraction control element 20) attached to its back end. This Nitinol structure 30 is designed to expand (once released from the constraints of the thin-walled outer tube 5) into a bell shaped crown (FIG. 29 ), the tips of which attach (circumferentially) the loop of a snare (i.e., the ligating element 32). In a preferred embodiment, the ligating element or snare 32 is composed of polypropylene or PTFE suture. The snare loop 32 is secured to the tips of the crown 30 in a reversible, easy-to-release fashion.
[0127] Once the left atrial appendage is secured with suction, the Nitinol structure 30, and its attached snare 32, is advanced over the flared tube 150 toward the left atrial appendage. The flared tube 150 extends 2 or 3 centimeters beyond the end of the thin-walled outer tube 5. As such, the Nitinol structure 30 begins to expand into a bell-shape which facilitates its advancement over the flared suction catheter 150, and over the left atrial appendage.
[0128] Once the Nitinol structure 30 has been advanced to the point where it is near the base of the left atrial appendage, the balloon 115 on the guide catheter 100 inside the appendage is inflated, preferably with a contrast material. The Nitinol structure is advanced under fluoroscopic guidance so that the tips of its bell-shaped crown 30 (and the suture snare 32) are beyond the inter-atrial balloon (FIG. 30 ). The snare 32 is then tightened by pulling on a strand of the suture that runs down the lumen of the stiff catheter 20 which is used to advance the Nitinol structure 30 (FIG. 31 ). With the suture snared, the guide catheter's balloon is deflated and the trans-septal left atrial catheter 100 is removed. The suture snare 32 is then preferably tightened again to account for the space previously occupied by the inter-atrial catheter 100. The Nitinol structure 30 releases away from the suture snare 32 when the snare is tightened. The ligating catheter 2 is then removed and the suture is cut at the skin.
Additional Constructions
[0129] In a preferred form of the present invention, and looking now at FIG. 32 , a wire 155 is passed through the left atrial appendage 130, through the wall of the left atrial appendage 130 and advanced through the pericardial space, whereby tip 165 of the left atrial appendage is perforated. Wire 155 can then be grasped by a catheter or snare in the pericardial space and pulled all the way through the pericardium and then out of the body, thereby creating a single wire track on which guide catheter 100, ligating catheter 2, and/or other devices can be passed along from either end of wire 155. With this construction, alignment element 90 on ligating catheter 2, and/or alignment element 102 on guide catheter 100 may be omitted if desired. Furthermore, with this embodiment of the invention, guide catheter 100 may be omitted altogether if desired.
[0130] Additionally, if desired one or more of the magnets 95 and/or 105 may comprise an electromagnet. Such a construction permits the magnetic field to be selectively turned on and off, thus facilitating separation of the devices at the end of the procedure.
[0131] Furthermore, in the foregoing description, struts 45 are described as being preferably expanded by connecting them to one another with springs 50, whereby to render the struts self-expandable when they are advanced out of the distal end of cylinder 5. Alternatively, struts 45 may be expanded by other means, e.g., an expansion mechanism mounted to struts 45, or by making struts 45 out of a spring material (e.g., a superelastic material such as Nitinol), etc.
Additional Aspects of the Present Invention
[0132] In one preferred form of the invention, the novel apparatus and method uniquely combine two or more of the following components:
[0133] (1) an elongated element such as a cylinder;
[0134] (2) an expandable element to help place the ligature over the tissue to be ligated;
[0135] (3) the ligature;
[0136] (4) an alignment mechanism; and
[0137] (5) an expandable element that helps guide the ligature into its proper position as the ligature is deployed.
[0138] In one aspect of the invention, an alignment system is provided for positioning a ligature delivery apparatus at a desired location around a tissue structure such as the left atrial appendage.
[0139] In another aspect of the invention, a tissue expander is provided for positioning a ligature at a desired location around a tissue structure such as the left atrial appendage.
[0140] And in another aspect of the invention, a radially-adjustable ligature delivery apparatus is provided for positioning a ligature at a desired location around a tissue structure such as the left atrial appendage. This delivery apparatus may be expandable.
[0141] In still another aspect of the invention, there is provided a ligature system which includes an alignment system, a tissue expander, and a radially-adjustable ligature delivery apparatus, and which is configured to position a ligature around a tissue structure such as a left atrial appendage.
[0142] And in still another aspect of the invention, there is provided a ligature system configured to position a ligature around a tissue structure such as the left atrial appendage without opening the chest.
[0143] And in still another aspect of the invention, there is provided a ligature system configured to position a ligature around a tissue structure such as the left atrial appendage without opening the chest, using at least two catheters entering the body from remote locations such as a vein, artery and/or through the skin.
[0144] In another aspect of the invention, there is provided a novel system comprising a guide member configured for placement within the left atrial appendage of a patient and adapted to provide a reference for positioning a ligature at a desired location around the left atrial appendage.
[0145] In yet another aspect of the invention, there is provided a ligature delivery apparatus having an alignment component configured for positioning a ligature at a desired location in response to the reference of the aforementioned guide member disposed within the left atrial appendage.
[0146] In still another aspect of the invention, there is provided a tissue expander configured for placement within the left atrial appendage and adapted to define a desired location for positioning a ligature.
[0147] In still another aspect of the invention, there is provided a reference catheter having both a guide member and a tissue expander for placement within the left atrial appendage.
[0148] In still another aspect of the invention, there is provided a radically-adjustable ligature delivery apparatus configured for placing a ligature at a desired location around the left atrial appendage of a patient.
[0149] In still another aspect of the invention, there is provided a delivery catheter having both an alignment component corresponding to the aforementioned guide member within the left atrial appendage of a patient and an adjustable ligature delivery apparatus for placing the ligature therearound.
[0150] In still another aspect of the invention, there is provided a delivery catheter having both an alignment component corresponding to the aforementioned guide member within the left atrial appendage of a patient and an adjustable ligature delivery apparatus for placing the ligature therearound, whereby the delivery apparatus contains an expandable element.
[0151] In still another aspect of the invention, there is provided a ligature system including both a reference catheter and an alignment catheter configured to correspond with one another so as to place a ligature at a desired location around the left atrial appendage of a patient.
[0152] In still another aspect of the invention, there is provided a ligature system including both a reference catheter and an alignment catheter configured to correspond with one another so as to place a ligature at a desired location around the left atrial appendage of a patient, in which either the reference catheter or the alignment catheter, or both, include an expandable element.
[0153] In another aspect of the invention, a device incorporating one or more of the above-identified components is placed in proximity to the tissue which is to be ligated. This can be done in many ways such as under direct visualization or under fluoroscopic, ultrasound, radiographic, CT, MRI, etc., guidance. Additionally, it can be further aligned by using such devices as alignment strands, magnets, etc.
[0154] And in another aspect of the invention, the apparatus and method may be used to ligate the left atrial appendage as follows. Access to the pericardial space is acquired using standard techniques such as the Seldinger over-the-wire technique. For example, such device, which preferably comprises an elongated device such as a cylinder containing an expandable element, a ligature, and an alignment mechanism, is placed into the pericardium over a guidewire. For example, the elongated device can be a large catheter in which there is an expandable element, a ligature, and an alignment mechanism.
[0155] And in another aspect of the invention, a guide catheter is placed into the left atrium using standard techniques, such as transseptally, through the veins or retrograde across the mitral valve, etc. The guide catheter in the left atrium is then placed into the left atrial appendage under fluoroscopic guidance. At this point, the guide catheter is in the left atrial appendage and the ligating mechanism is disposed in connection with a deployment catheter in the pericardial space. The guide catheter in the left atrium and the deployment catheter in the pericardial space are then aligned with one another. This can be done using a variety of techniques. For example, one or both of the devices can be magnetized, thus allowing them to be aligned relative to one another using magnetic force. Alternatively, the guide catheter and deployment catheter can be “steered” into proximity using visual or ultrasonic guidance. Or the guide catheter in the left atrium can penetrate the left atrial appendage and be “snared” by the deployment catheter in the pericardium. At this point, the device in the pericardium is advanced into proximity with the left atrial appendage. A ligating apparatus is then deployed from the deployment catheter and advanced over the left atrial appendage. Preferably, the guide catheter inside the left atrium includes an expandable element such as a balloon. This expandable element is then expanded inside the left atrial appendage. In so doing, this expansion helps prevent the ligature from slipping or migrating off of the left atrial appendage as the ligature is tightened around the left atrial appendage. The ligature is then tightened around the left atrial appendage. The expandable element inside the left atrium is then contracted. The guide catheter inside the left atrial appendage is then backed out of the left atrial appendage. The procedure can be repeated as necessary. The guide catheter and deployment catheter are then removed from the body cavity.
[0156] Alternatively, the guide catheter inside the left atrial appendage may be removed after the ligature has been mostly placed, but before the final tightening of the ligature. This will allow the base of the left atrial appendage to be completely occluded after the guide catheter is withdrawn from the left atrial appendage.
[0157] The following text further illustrates a preferred manner for ligating the left atrial appendage. A trans-septal left atrial guide catheter that has (integral to its construction) a rare-earth magnet, or other alignment means, and an inflatable balloon, is of great utility in effectively occluding the left atrial appendage with a snare or ligature. The left atrial appendage is typically roughly conical in shape, with a slight neck or narrowing in the plane of the orifice where it joins the left atrium proper. To effectively exclude the left atrial appendage from the outside with a ligature or snare, the snare must be tightened precisely in this plane. Ideally, with the ligature tightened, the resultant left atrial geometry should be essentially spherical, with only a slight dimple visible from the endocardial or luminal aspect at the site of the obliterated orifice. If the snare is tightened above the plane of the orifice (toward the left atrial appendage tip), incomplete exclusion of the left atrial appendage may result in a persistent diverticulum of left atrial appendage, which may provide a site of stasis and thrombus formation in the fibrillating atrium. Conversely, if the snare is tightened below the plane of the orifice, there is a risk of injury to the circumflex coronary artery, which runs in the atrio-ventricular grove.
[0158] Snaring the left atrial appendage precisely and accurately in the optimal plane presents several technical challenges. In some individuals, the geometry of the left atrium and left atrial appendage may be such that the neck or narrowing between them is poorly defined, especially from the epicardial or outer aspect. Furthermore, because the left atrial appendage wall is thin and flexible, and the wall tension low (left atrial pressure is generally low, e.g., <20 mm Hg), the external geometry of the left atrial appendage-left atrial junction may be of little help in constraining the snare to the correct plane during tightening. This challenge is compounded by the fact that the anatomy is moving vigorously, even in the fibrillating atrium, due to translational motion from ventricular systole. A trans-septal left atrial guide catheter equipped with a magnetic tip and a large inflatable balloon such as described above enables snaring the left atrial appendage in the proper plane. More particularly, it is believed that identifying and capturing the tip of the left atrial appendage using just an intra-pericardial instrument under fluoroscopic or echocardiographic guidance may prove prohibitively challenging. At the same time, passing a catheter across the atrial septum into the left atrium, and subsequently positioning it in the apex of the left atrial appendage, is readily accomplished by those skilled in the art with catheters that are commercially available. Thus, positioning a guide catheter with a rare-earth magnet (or other alignment mechanism) at the tip thereof in the left atrial appendage is readily achievable and thereby allows fluoroscopic guidance as to the position of the left atrial appendage apex, as well as enabling precise capturing of the apex with an intra-pericardial tool.
[0159] A balloon near the tip of the trans-septal left atrial guide catheter greatly facilitates positioning and tightening of the snare or ligature in the proper plane of the orifice between the left atrial appendage and left atrium. Preferably, the balloon is designed to inflate to approximately the size of the left atrial appendage. As the balloon is inflated, it is confined to the left atrial appendage by the neck or narrowing at the orifice between left atrial appendage and left atrium. This may be readily confirmed by echocardiographic examination, or fluoroscopy, especially if the balloon is inflated with a contrast agent. Separate ports in the guide catheter allow the contrast agent to be injected into the left atrial appendage and/or the left atrium proper to provide further confirmation of correct position of the inflated balloon.
[0160] The inflated balloon accentuates external geometric features at the left atrial appendage-left atrial junction. When the spherical balloon is inflated, the flexible left atrial appendage is distended and its shape changed (e.g., to spherical) to facilitate ligation. The junction between the left atrial appendage and left atrium becomes better defined, like a waist of a snowman. This constrains the snare or ligature to the proper plane during tightening. The balloon, and consequently the left atrial appendage, is inflated to a pressure significantly higher than that of the left atrium proper. As such, there is a significant differential in wall tension between the left atrial appendage and the left atrium. As the balloon is spherical, an attempt at snaring above the plane will result in the snare slipping off of the tense spherical surface toward the low tension, flexible neck. Radio-opaque contrast agent in the balloon, the ability to selectively inject contrast in the left atrial appendage and/or left atrium proper, and a radio-opaque snare or ligature greatly facilitate performing these procedures under fluoroscopic guidance. Once the left atrial appendage-left atrial junction is snared, the balloon is deflated and removed and the snare tightened completely.
[0161] In general, it should be appreciated that, among other things, the invention comprises the alignment of two devices, one within and one outside of a lumen, cardiac chamber, etc. Thus, the present invention could be used in the stomach to help with an endoscopic fundiplication.
[0162] The foregoing description is intended to illustrate preferred embodiments of the present invention. However, numerous changes may be made to the preferred embodiments without departing from the scope of the present invention. Thus, one or more of the steps of the method, and/or one or more of the components of the apparatus, may be modified or omitted. Also, the present apparatus and method may be used to ligate any tissue or like structure in the body.
Claims
What is claimed is:
1. A method for closing a left atrial appendage of a patient's heart, comprising:
advancing a first guide member transeptally into the left atrial appendage, wherein the first guide member has a first alignment element for coupling with a counterpart alignment element on a second guide member, the first alignment element located at a distal end of the first guide member;
advancing a second guide member from the outside of the patient's heart into a pericardial space of the patient, wherein the second guide member has a second alignment element located at a distal end thereof;
aligning the first and second alignment elements, such that the alignment members couple;
advancing a ligating element over the left atrial appendage, wherein the ligating element is advanced with respect to the second guide member; and
closing the left atrial appendage using the ligating element.
2. The method of claim 1, wherein the first guide member further comprises radiopaque material, and wherein the first guide member is visualized using fluoroscopy.
3. The method of claim 1, wherein the first guide member is visualized using ultrasound.
4. The method of claim 1, wherein the first guide member further comprises an expandable element located near the distal end.
5. The method of claim 4, further comprising expanding the expandable element within the left atrial appendage before closing the left atrial appendage using the ligating element.
6. The method of claim 4, wherein the expandable element is an inflatable balloon.
7. The method of claim 1, wherein the first and second alignment elements are magnets.
8. The method of claim 1, wherein the pericardial space is accessed by making an incision below the xyphoid process.
9. The method of claim 1, wherein the pericardial space is accessed by making an incision over the second costal cartilage.
10. The method of claim 1, wherein the ligating element comprises a nitinol structure with a suture.
11. The method of claim 1, wherein the ligating element comprises a suture.
12. The method of claim 11, wherein the suture is made from polypropylene or PTFE.
13. The method of claim 1, wherein the first guide member is coupled to an expandable element.
14. The method of claim 13, wherein the expandable element is an inflatable balloon.
15. The method of claim 1, wherein the pericardial space is accessed by using a series of dilators.
Patent Citations (266)
| Patent | Date | Inventor | Cited By |
|---|---|---|---|
| US3496932(A) | 1970-02-01 | Prisk et al. | Applicant |
| US3999555(A) | 1976-12-01 | Person | Applicant |
| US4030509(A) | 1977-06-01 | Heilman et al. | Applicant |
| US4181123(A) | 1980-01-01 | Crosby | Applicant |
| US4249536(A) | 1981-02-01 | Vega | Applicant |
| US4257278(A) | 1981-03-01 | Papadofrangakis et al. | Applicant |
| US4319562(A) | 1982-03-01 | Crosby | Applicant |
| US4662377(A) | 1987-05-01 | Heilman et al. | Applicant |
| US4765341(A) | 1988-08-01 | Mower et al. | Applicant |
| US4817608(A) | 1989-04-01 | Shapland et al. | Applicant |
| US4901405(A) | 1990-02-01 | Grover et al. | Examiner |
| US4944753(A) | 1990-07-01 | Burgess et al. | Applicant |
| US4991578(A) | 1991-02-01 | Cohen | Applicant |
| US4991603(A) | 1991-02-01 | Cohen et al. | Applicant |
| US4998975(A) | 1991-03-01 | Cohen et al. | Applicant |
| US5033477(A) | 1991-07-01 | Chin et al. | Applicant |
| US5163946(A) | 1992-11-01 | Li | Applicant |
| US5176691(A) | 1993-01-01 | Pierce | Applicant |
| US5181123(A) | 1993-01-01 | Swank | Applicant |
| US5226908(A) | 1993-07-01 | Yoon | Examiner |
| US5243977(A) | 1993-09-01 | Trabucco et al. | Applicant |
| US5269326(A) | 1993-12-01 | Verrier | Applicant |
| US5281238(A) | 1994-01-01 | Chin et al. | Applicant |
| US5300078(A) | 1994-04-01 | Buelna | Applicant |
| US5306234(A) | 1994-04-01 | Johnson | Applicant |
| US5336252(A) | 1994-08-01 | Cohen | Applicant |
| US5385156(A) | 1995-01-01 | Oliva | Applicant |
| US5387219(A) | 1995-02-01 | Rappe | Examiner |
| US5403331(A) | 1995-04-01 | Chesterfield et al. | Applicant |
| US5423821(A) | 1995-06-01 | Pasque | Applicant |
| US5433457(A) | 1995-07-01 | Wright | Applicant |
| US5433730(A) | 1995-07-01 | Alt | Applicant |
| US5498228(A) | 1996-03-01 | Royalty et al. | Applicant |
| US5624430(A) | 1997-04-01 | Eton et al. | Examiner |
| US5634895(A) | 1997-06-01 | Igo et al. | Applicant |
| US5676162(A) | 1997-10-01 | Larson, Jr. et al. | Applicant |
| US5676651(A) | 1997-10-01 | Larson, Jr. et al. | Applicant |
| US5678547(A) | 1997-10-01 | Faupel et al. | Applicant |
| US5681278(A) | 1997-10-01 | Igo et al. | Applicant |
| US5682906(A) | 1997-11-01 | Sterman et al. | Applicant |
| US5683364(A) | 1997-11-01 | Zadini et al. | Applicant |
| US5683445(A) | 1997-11-01 | Swoyer | Applicant |
| US5693091(A) | 1997-12-01 | Larson, Jr. et al. | Applicant |
| US5702430(A) | 1997-12-01 | Larson, Jr. et al. | Applicant |
| US5707336(A) | 1998-01-01 | Rubin | Applicant |
| US5716367(A) | 1998-02-01 | Koike et al. | Applicant |
| US5716392(A) | 1998-02-01 | Bourgeois et al. | Applicant |
| US5728151(A) | 1998-03-01 | Garrison et al. | Applicant |
| US5735877(A) | 1998-04-01 | Pagedas | Applicant |
| US5752526(A) | 1998-05-01 | Cosgrove | Applicant |
| US5766216(A) | 1998-06-01 | Gangal et al. | Examiner |
| US5766217(A) | 1998-06-01 | Christy | Applicant |
| US5769863(A) | 1998-06-01 | Garrison | Applicant |
| US5779727(A) | 1998-07-01 | Orejola | Applicant |
| US5792151(A) | 1998-08-01 | Heck et al. | Applicant |
| US5797870(A) | 1998-08-01 | March et al. | Applicant |
| US5797929(A) | 1998-08-01 | Andreas et al. | Applicant |
| US5797946(A) | 1998-08-01 | Chin | Applicant |
| US5799661(A) | 1998-09-01 | Boyd et al. | Applicant |
| US5823946(A) | 1998-10-01 | Chin | Applicant |
| US5827216(A) | 1998-10-01 | Igo et al. | Applicant |
| US5840059(A) | 1998-11-01 | March et al. | Applicant |
| US5865791(A) | 1999-02-01 | Whayne et al. | Applicant |
| US5871531(A) | 1999-02-01 | Struble | Applicant |
| US5873876(A) | 1999-02-01 | Christy | Applicant |
| US5879375(A) | 1999-03-01 | Larson, Jr. et al. | Applicant |
| US5882299(A) | 1999-03-01 | Rastegar et al. | Applicant |
| US5895298(A) | 1999-04-01 | Faupel et al. | Applicant |
| US5897586(A) | 1999-04-01 | Molina | Applicant |
| US5900433(A) | 1999-05-01 | Igo et al. | Applicant |
| US5908429(A) | 1999-06-01 | Yoon | Applicant |
| US5908435(A) | 1999-06-01 | Samuels | Examiner |
| US5910124(A) | 1999-06-01 | Rubin | Applicant |
| US5910129(A) | 1999-06-01 | Koblish et al. | Applicant |
| US5921994(A) | 1999-07-01 | Andreas et al. | Applicant |
| US5924424(A) | 1999-07-01 | Stevens et al. | Applicant |
| USRE36269(E) | 1999-08-01 | Wright | Applicant |
| US5941819(A) | 1999-08-01 | Chin | Applicant |
| US5961440(A) | 1999-10-01 | Schweich, Jr. et al. | Applicant |
| US5964699(A) | 1999-10-01 | Rullo et al. | Applicant |
| US5968010(A) | 1999-10-01 | Waxman et al. | Applicant |
| US5972013(A) | 1999-10-01 | Schmidt | Applicant |
| US5984866(A) | 1999-11-01 | Rullo et al. | Applicant |
| US5984917(A) | 1999-11-01 | Fleischman et al. | Applicant |
| US5991668(A) | 1999-11-01 | Leinders et al. | Applicant |
| US5997525(A) | 1999-12-01 | March et al. | Applicant |
| US6006122(A) | 1999-12-01 | Smits | Applicant |
| US6010531(A) | 2000-01-01 | Donlon et al. | Applicant |
| US6015382(A) | 2000-01-01 | Zwart et al. | Applicant |
| US6045570(A) | 2000-04-01 | Epstein et al. | Applicant |
| US6048329(A) | 2000-04-01 | Thompson et al. | Applicant |
| US6059750(A) | 2000-05-01 | Fogarty et al. | Applicant |
| US6071281(A) | 2000-06-01 | Burnside et al. | Applicant |
| US6081738(A) | 2000-06-01 | Hinohara et al. | Applicant |
| US6083153(A) | 2000-07-01 | Rullo et al. | Applicant |
| US6090042(A) | 2000-07-01 | Rullo et al. | Applicant |
| US6095968(A) | 2000-08-01 | Snyders | Applicant |
| US6110170(A) | 2000-08-01 | Taylor et al. | Applicant |
| US6120431(A) | 2000-09-01 | Magovern et al. | Applicant |
| US6132438(A) | 2000-10-01 | Fleischman et al. | Applicant |
| US6148230(A) | 2000-11-01 | KenKnight | Applicant |
| US6149595(A) | 2000-11-01 | Seitz et al. | Applicant |
| US6152144(A) | 2000-11-01 | Lesh et al. | Applicant |
| US6152920(A) | 2000-11-01 | Thompson et al. | Applicant |
| US6152936(A) | 2000-11-01 | Christy et al. | Examiner |
| US6155968(A) | 2000-12-01 | Wilk | Applicant |
| US6157852(A) | 2000-12-01 | Selmon et al. | Applicant |
| US6161543(A) | 2000-12-01 | Cox et al. | Applicant |
| US6162195(A) | 2000-12-01 | Igo et al. | Applicant |
| US6167889(B1) | 2001-01-01 | Benetti | Applicant |
| US6199556(B1) | 2001-03-01 | Benetti et al. | Applicant |
| US6200303(B1) | 2001-03-01 | Verrior et al. | Applicant |
| US6206004(B1) | 2001-03-01 | Schmidt et al. | Applicant |
| US6224584(B1) | 2001-05-01 | March et al. | Applicant |
| US6231518(B1) | 2001-05-01 | Grabek et al. | Applicant |
| US6237605(B1) | 2001-05-01 | Vaska et al. | Applicant |
| US6241667(B1) | 2001-06-01 | Vetter et al. | Applicant |
| US6258021(B1) | 2001-07-01 | Wilk | Applicant |
| US6266550(B1) | 2001-07-01 | Selmon et al. | Applicant |
| US6280415(B1) | 2001-08-01 | Johnson | Applicant |
| US6283127(B1) | 2001-09-01 | Sterman et al. | Applicant |
| US6290674(B1) | 2001-09-01 | Roue et al. | Applicant |
| US6293906(B1) | 2001-09-01 | Vanden Hoek et al. | Applicant |
| US6296630(B1) | 2001-10-01 | Altman et al. | Applicant |
| US6311692(B1) | 2001-11-01 | Vaska et al. | Applicant |
| US6311693(B1) | 2001-11-01 | Sterman et al. | Applicant |
| US6314962(B1) | 2001-11-01 | Vaska et al. | Applicant |
| US6314963(B1) | 2001-11-01 | Vaska et al. | Applicant |
| US6319201(B1) | 2001-11-01 | Wilk | Applicant |
| US6333347(B1) | 2001-12-01 | Hunter et al. | Applicant |
| US6346074(B1) | 2002-02-01 | Roth | Applicant |
| US6379366(B1) | 2002-04-01 | Fleischman et al. | Applicant |
| US6423051(B1) | 2002-07-01 | Kaplan et al. | Applicant |
| US6474340(B1) | 2002-11-01 | Vaska et al. | Applicant |
| US6485407(B2) | 2002-11-01 | Alferness et al. | Applicant |
| US6488689(B1) | 2002-12-01 | Kaplan et al. | Applicant |
| US6561969(B2) | 2003-05-01 | Frazier et al. | Applicant |
| US6592552(B1) | 2003-07-01 | Schmidt | Applicant |
| US6610055(B1) | 2003-08-01 | Swanson et al. | Applicant |
| US6610072(B1) | 2003-08-01 | Christy et al. | Applicant |
| US6613062(B1) | 2003-09-01 | Leckrone et al. | Applicant |
| US6652555(B1) | 2003-11-01 | Van Tassel et al. | Applicant |
| US6656175(B2) | 2003-12-01 | Francischelli et al. | Applicant |
| US6666861(B1) | 2003-12-01 | Grabek | Examiner |
| US6692491(B1) | 2004-02-01 | Phan | Applicant |
| US6733509(B2) | 2004-05-01 | Nobles et al. | Applicant |
| US6736774(B2) | 2004-05-01 | Benetti et al. | Applicant |
| US6755338(B2) | 2004-06-01 | Hahnen et al. | Applicant |
| US6786898(B2) | 2004-09-01 | Guenst | Applicant |
| US6830174(B2) | 2004-12-01 | Hillstead et al. | Applicant |
| US6830576(B2) | 2004-12-01 | Fleischman et al. | Examiner |
| US6985776(B2) | 2006-01-01 | Kane et al. | Examiner |
| US7011671(B2) | 2006-03-01 | Welch | Applicant |
| US7056294(B2) | 2006-06-01 | Khairkhahan et al. | Applicant |
| US7063682(B1) | 2006-06-01 | Whayne et al. | Applicant |
| US7063693(B2) | 2006-06-01 | Guenst | Applicant |
| US7175619(B2) | 2007-02-01 | Koblish et al. | Applicant |
| US7186214(B2) | 2007-03-01 | Ness | Applicant |
| US7207988(B2) | 2007-04-01 | Leckrone et al. | Applicant |
| US7226440(B2) | 2007-06-01 | Gelfand et al. | Applicant |
| US7226458(B2) | 2007-06-01 | Kaplan et al. | Applicant |
| US7264587(B2) | 2007-09-01 | Chin | Applicant |
| US7294115(B1) | 2007-11-01 | Wilk | Examiner |
| US7297144(B2) | 2007-11-01 | Fleischman et al. | Applicant |
| US7309328(B2) | 2007-12-01 | Kaplan et al. | Applicant |
| US7318829(B2) | 2008-01-01 | Kaplan et al. | Applicant |
| US7722641(B2) | 2010-05-01 | van der Burg et al. | Applicant |
| US2001/0025132(A1) | 2001-09-01 | Alferness et al. | Applicant |
| US2002/0017306(A1) | 2002-02-01 | Cox et al. | Applicant |
| US2002/0049457(A1) | 2002-04-01 | Kaplan et al. | Examiner |
| US2002/0058925(A1) | 2002-05-01 | Kaplan et al. | Applicant |
| US2002/0062136(A1) | 2002-05-01 | Hillstead et al. | Applicant |
| US2002/0068970(A1) | 2002-06-01 | Cox et al. | Applicant |
| US2002/0099390(A1) | 2002-07-01 | Kaplan et al. | Applicant |
| US2002/0103492(A1) | 2002-08-01 | Kaplan et al. | Applicant |
| US2002/0111636(A1) | 2002-08-01 | Fleischman et al. | Applicant |
| US2002/0111637(A1) | 2002-08-01 | Kaplan et al. | Applicant |
| US2003/0014049(A1) | 2003-01-01 | Koblish et al. | Applicant |
| US2003/0024537(A1) | 2003-02-01 | Cox et al. | Applicant |
| US2003/0045900(A1) | 2003-03-01 | Hahnen et al. | Applicant |
| US2003/0069577(A1) | 2003-04-01 | Vaska et al. | Applicant |
| US2003/0083542(A1) | 2003-05-01 | Alferness et al. | Applicant |
| US2003/0109863(A1) | 2003-06-01 | Francischelli et al. | Applicant |
| US2003/0120264(A1) | 2003-06-01 | Lattouf | Applicant |
| US2003/0158464(A1) | 2003-08-01 | Bertolero | Applicant |
| US2003/0187460(A1) | 2003-10-01 | Chin et al. | Applicant |
| US2003/0236535(A1) | 2003-12-01 | Onuki et al. | Applicant |
| US2004/0030335(A1) | 2004-02-01 | Zenati et al. | Examiner |
| US2004/0044361(A1) | 2004-03-01 | Frazier et al. | Applicant |
| US2004/0049210(A1) | 2004-03-01 | VanTassel et al. | Examiner |
| US2004/0064138(A1) | 2004-04-01 | Grabek | Applicant |
| US2004/0078069(A1) | 2004-04-01 | Francischelli et al. | Applicant |
| US2004/0102804(A1) | 2004-05-01 | Chin | Applicant |
| US2004/0106918(A1) | 2004-06-01 | Cox et al. | Applicant |
| US2004/0111101(A1) | 2004-06-01 | Chin | Applicant |
| US2004/0225212(A1) | 2004-11-01 | Okerlund et al. | Applicant |
| US2004/0243176(A1) | 2004-12-01 | Hahnen et al. | Applicant |
| US2004/0260273(A1) | 2004-12-01 | Wan | Applicant |
| US2005/0033280(A1) | 2005-02-01 | Francischelli et al. | Applicant |
| US2005/0033287(A1) | 2005-02-01 | Sra | Applicant |
| US2005/0033321(A1) | 2005-02-01 | Fleischman et al. | Applicant |
| US2005/0043745(A1) | 2005-02-01 | Alferness et al. | Applicant |
| US2005/0107824(A1) | 2005-05-01 | Hillstead et al. | Applicant |
| US2005/0149068(A1) | 2005-07-01 | Williams et al. | Applicant |
| US2005/0149069(A1) | 2005-07-01 | Bertolero et al. | Applicant |
| US2005/0154376(A1) | 2005-07-01 | Riviere et al. | Applicant |
| US2005/0154404(A1) | 2005-07-01 | Liddicoat | Applicant |
| US2005/0165466(A1) | 2005-07-01 | Morris et al. | Applicant |
| US2006/0004388(A1) | 2006-01-01 | Whayne et al. | Applicant |
| US2006/0009715(A1) | 2006-01-01 | Khairkhahan et al. | Applicant |
| US2006/0020162(A1) | 2006-01-01 | Whayne et al. | Applicant |
| US2006/0020271(A1) | 2006-01-01 | Stewart et al. | Applicant |
| US2006/0020336(A1) | 2006-01-01 | Liddicoat | Applicant |
| US2006/0247672(A1) | 2006-11-01 | Vidlund et al. | Applicant |
| US2006/0253129(A1) | 2006-11-01 | Liddicoat et al. | Applicant |
| US2007/0016228(A1) | 2007-01-01 | Salas | Applicant |
| US2007/0027456(A1) | 2007-02-01 | Gartner et al. | Applicant |
| US2007/0060951(A1) | 2007-03-01 | Shannon | Applicant |
| US2007/0083082(A1) | 2007-04-01 | Kiser et al. | Applicant |
| US2007/0083225(A1) | 2007-04-01 | Kiser et al. | Applicant |
| US2007/0083232(A1) | 2007-04-01 | Lee | Applicant |
| US2007/0100405(A1) | 2007-05-01 | Thompson et al. | Applicant |
| US2007/0135822(A1) | 2007-06-01 | Onuki et al. | Applicant |
| US2007/0149988(A1) | 2007-06-01 | Michler et al. | Applicant |
| US2007/0179345(A1) | 2007-08-01 | Santilli | Applicant |
| US2007/0249991(A1) | 2007-10-01 | Whayne et al. | Applicant |
| US2007/0260278(A1) | 2007-11-01 | Wheeler et al. | Applicant |
| US2007/0270891(A1) | 2007-11-01 | McGuckin, Jr. | Applicant |
| US2008/0009843(A1) | 2008-01-01 | de la Torre | Applicant |
| US2008/0033241(A1) | 2008-02-01 | Peh et al. | Examiner |
| US2008/0033457(A1) | 2008-02-01 | Francischelli et al. | Applicant |
| US2008/0039879(A1) | 2008-02-01 | Chin et al. | Applicant |
| US2008/0097489(A1) | 2008-04-01 | Goldfarb et al. | Applicant |
| US2008/0147097(A1) | 2008-06-01 | Liddicoat et al. | Applicant |
| US2008/0221593(A1) | 2008-09-01 | Liddicoat et al. | Applicant |
| US2008/0294174(A1) | 2008-11-01 | Bardsley et al. | Applicant |
| US2008/0294175(A1) | 2008-11-01 | Bardsley et al. | Applicant |
| US2008/0312664(A1) | 2008-12-01 | Bardsley et al. | Applicant |
| US2009/0043317(A1) | 2009-02-01 | Cavanaugh et al. | Applicant |
| US2009/0082797(A1) | 2009-03-01 | Fung et al. | Applicant |
| US2009/0143791(A1) | 2009-06-01 | Miller et al. | Applicant |
| US2009/0157118(A1) | 2009-06-01 | Miller et al. | Applicant |
| US2010/0174296(A1) | 2010-07-01 | Vakharia et al. | Applicant |
| EP598219(A2) | 1994-05-01 | Applicant | |
| EP598219(A3) | 1994-05-01 | Applicant | |
| EP598219(B1) | 1994-05-01 | Applicant | |
| EP1010397(A1) | 2000-06-01 | Applicant | |
| GB1506142(A) | 1978-04-01 | Applicant | |
| WO-96/40356(A1) | 1996-12-01 | Applicant | |
| WO-2004/002327(A1) | 2004-01-01 | Applicant | |
| WO-2004/066828(A2) | 2004-08-01 | Applicant | |
| WO-2004/066828(A3) | 2004-08-01 | Applicant | |
| WO-2005/034767(A1) | 2005-04-01 | Applicant | |
| WO-2005/034767(C2) | 2005-04-01 | Applicant | |
| WO-2005/034802(A2) | 2005-04-01 | Applicant | |
| WO-2005/034802(A3) | 2005-04-01 | Applicant | |
| WO-2006/110734(A2) | 2006-10-01 | Applicant | |
| WO2006/115689 | 2006-11-01 | Applicant | |
| WO-2007/056502(A1) | 2007-05-01 | Applicant | |
| WO-2008/036408(A2) | 2008-03-01 | Applicant | |
| WO-2008/036408(A3) | 2008-03-01 | Applicant | |
| WO-2008/091612(A2) | 2008-07-01 | Applicant | |
| WO-2008/091612(A3) | 2008-07-01 | Applicant | |
| WO-2008/121278(A2) | 2008-10-01 | Applicant | |
| WO-2009/039191(A2) | 2009-03-01 | Applicant | |
| WO-2009/094237(A1) | 2009-07-01 | Applicant |
Non-Patent Literature (191)
- Blackshear, J.L., et al. “Thorascopic Extracardiac Obliteration of the Left Atrial Appendage for Stroke Risk Reduction in Atrial Fibrillation” J. Am. Coll. Cardiol. 42:1249-52 (2003).Applicant
- Cox, J.L. et al. “Impact of the Maze Procedure on the Stroke Rate in Patients with Atrial Fibrillation” J Thorac Cardiovasc Surg 118: 833-40 (Nov. 1999).Applicant
- Cox, J.L. et al. “Modification of the MAZE Procedure for Atrial Flutter and Atrial Fibrillation I. Rationale and surgical results.” J. Thorac. Cardiovasc. Surg. 110(2): 473-84 (Aug. 1995).Applicant
- Cox, J.L. et al. “Modification of the MAZE Procedure for Atrial Flutter and Atrial Fibrillation II. Surgical technique of the maze III procedure.” J. Thorac. Cardiovasc. Surg. 110(2): 485-95 (Aug. 1995).Applicant
- Cox, J.L. et al. “The surgical treatment of atrial fibrillation IV. Surgical technique” J Thorac Cardiovasc Surg 101(4): 584-92 (1991).Applicant
- Dullum, M.K.C., et al. “Xyphoid MIDCAB : Report of the Technique and Experience with a Less Invasive MIDCAB Procedure” Heart Surg Forum 2(1): 77-81 (1999).Applicant
- Kim, K.B. et al. “Effect of the Cox maze procedure on the secretion of atrial natriuretic peptide” J Thorac Cardiovasc Surg Jan. 1998;115(1):139-46; discussion 146-7.Applicant
- Macris, M., et al “Minimally Invasive Access of the Normal Pericardium: Initial Clinical Experience with a Novel Device” Clin. Cardiol. vol. 22 (Suppl. I), I-36-I-39 (Jan. 1999).Applicant
- Morris, J.J., Jr. “Transvenous versus Transthoracic Cardiac Pacing” Cardiac Pacing Ch 16: 239-45 (1997).Applicant
- Naclerio, et al. “Surgical Techniques for Permanent Ventricular Pacing.” Cardiac Pacing Ch 10:145-168 (1997).Applicant
- Odell, J.A. et al., “Thorascopic Obliteration of the Left Atrial Appendage: Potential for Stroke Reduction?” Ann Thorac Surg 61:565-69 (1996).Applicant
- Seferovic, P., et al. “Initial Clinical Experience with the Perducer Device: Promising New Tool in the diagnosis and treatment of pericardial disease.” Clin. Cardiol vol. 22 (Supp. I), I-30-I35 (Jan. 1999).Applicant
- Sosa, E., et al. “A New Technique to Perform Epicardial Mapping in the EP Laboratory.” J Cardiovasc Electrophysiol 7(6):531-536 (1996).Applicant
- Sosa, E., et al. “Endocardial and Epicardial Ablation Guided by Nonsurgical Transthoracic Epicardial Mapping to Treat Recurrent Ventricular Tachycardia.” J. Cardiovasc. Electrophysiol. 9(3): 229-39 (Mar. 1998).Applicant
- Sosa, E., et al. “Different Ways of Approaching the Normal Pericardial Space.” Circulation 100(24): e115-6 (Dec. 14, 1999).Applicant
- Stewart, S. “Placement of the Sutureless Epicardial Pacemaker Lead by the Subxiphoid Approach” Ann of Thoracic Surg 18(3):308-313 (1974).Applicant
- Stokes, K. “Implantable Pacing Lead Technology” IEEE Engineering in Medicine and Biology 43-49 (Jun. 1990).Applicant
- Suehiro, S. et al. “Echocardiography-Guided Pericardiocentesis With a Needle Attached to a Probe” Ann Thorac Surg 61:741-42 (1996).Applicant
- Watkins, L, et al. “Implantation of the Automatic Defibrillator: The Subxiphoid approach.” Ann of Thoracic Surg. 34(5):514-520 (Nov. 1982).Applicant
- Non-Final Office Action mailed on Mar. 13, 2008 for U.S. Appl. No. 10/963,371, filed Oct. 11, 2004, 13 pages.Applicant
- Non-Final Office Action mailed on Aug. 6, 2008 for U.S. Appl. No. 10/963,371, filed Oct. 11, 2004, 14 pages.Applicant
- U.S. Appl. No. 12/363,359, filed Jan. 30, 2009, for Miller et al.Applicant
- U.S. Appl. No. 12/363,381, filed Jan. 30, 2009, for Miller et al.Applicant
- AFIBFACTS.COM (Date Unknown). “Cox-Maze III: The Gold Standard Treatment for Atrial Fibrillation: Developing a Surgical Option for Atrial Fibrillation,” located at <http://www.afibfacts.com/Treatment—Options—for—Atrial—Fibrillation/Cox-Maze—III%—3a—The—Gold—Standard—Treatment—for—Atrial—Fibrillation >, last visited on Apr. 20, 2007, 4 pages.Applicant
- Al-Saady, N. M. et al. (1999). “Left Atrial Appendage: Structure, Function, and Role in Thromboembolism,” Heart 82:547-554.Applicant
- Albers, G.W. (Jul. 11, 1994). “Atrial Fibrillation and Stroke: Three New Studies, Three Remaining Questions,” Arch Intern Med 154:1443-1448.Applicant
- Alonso, M. et al. (Mar. 4, 2003). “Complications With Femoral Access in Cardiac Catheterization. Impact of Previous Systematic Femoral Angiography and Hemostasis With VasoSeal-Es® Collagen Plug,” Rev. Esp. Cardiol. 56(6):569-577.Applicant
- Aronow, W.S. et al. (Apr. 2009). “Atrial Fibrillation: The New Epidemic of the Ageing World,” Journal of Atrial Fibrillation 1(6):337-361.Applicant
- Babaliaros, V.C. et al. (Jun. 3, 2008). “Emerging Applications for Transseptal Left Heart Catheterization: Old Techniques for New Procedures,” Journal of the American College of Cardiology 51(22) 2116-2122.Applicant
- Bath, P.M.W. et al. (2005). “Current Status of Stroke Prevention in Patients with Atrial Fibrillation,” European Heart Journal Supplements 7(Supplement C):C12-C18.Applicant
- Benjamin, B.A. et al. (1994). “Effect of Bilateral Atrial Appendectomy on Postprandial Sodium Excretion in Conscious Monkeys,” Society for Experimental Biology and Medicine 2006: 1 page.Applicant
- Beygui, F. et al. (2005, e-pub. Oct. 21, 2005). “Multimodality Imaging of Percutaneous Closure of the Left Atrial Appendage,” Clinical Vignette, 1 page.Applicant
- Bisleri, G. et al. (Jun. 3, 2005). “Innovative Monolateral Approach for Closed-Chest Atrial Fibrillation Surgery,” The Annals of Thoracic Surgery 80:e22-e25.Applicant
- Björk, V.O. et al. (Aug. 1961). “Sequelae of Left Ventricular Puncture with Angiocardiography,” Circulation 24:204-212.Applicant
- Blackshear, J.L. et al. (Feb. 1996). “Appendage Obliteration to Reduce Stroke in Cardiac Surgical Patients With Atrial Fibrillation,” Ann. Thorac. Surg. 61(2), 13 pages.Applicant
- Bonanomi, G. et al. (Jan. 1, 2003). “Left Atrial Appendectomy and Maze,” Journal of the American College of Cardiology 41(1):169-171.Applicant
- Bonow, R.O. et al. (1998). “Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease),” Journal of the American Heart Association 98:1949-1984.Applicant
- Botham, R.J. et al. (1959). “Pericardial Tamponade Following Percutaneous Left Ventricular Puncture,” Circulation 19:741-744.Applicant
- Brock, R. et al. (1956). “Percutaneous Left Ventricular Puncture in the Assessment of Aortic Stenosis,” Thorax 11:163-171.Applicant
- Burke, R.P. et al. (1992). “Improved Surgical Approach to Left Atrial Appendage Aneurysm,” Journal of Cardiac Surgery 7(2):104-107.Applicant
- Canaccord Adams (Aug. 11, 2008). “A-Fib: Near A Tipping Point,” 167 pages.Applicant
- Chung, M.K. (Jul. 2003). “Current Clinical Issues in Atrial Fibrillation,” Cleveland Clinic Journal of Medicine 70(Supp. 3):S6-S11.Applicant
- Coffin, L.H. (Jun. 1985). “Use of the Surgical Stapler to Obliterate the Left Atrial Appendage,” Surgery, Gynecology & Obstetric 160:565-566.Applicant
- Connolly, S.J. (Sep. 7, 1999). “Preventing Stroke in Atrial Fibrillation: Why Are So Many Eligible Patients Not Receiving Anticoagulant Therapy?” Canadian Medical Association 161(5):533-534.Applicant
- Costa, R. et al. (2006). “Bi-Atrial Subxiphoid Epicardial Pacemaker in Superior Vena Cava Syndrome,” Arq. Bras. Cardiol. 87:e45-e47.Applicant
- Cox, J.L. et al. (2004). “The Role of Surgical Intervention in the Management of Atrial Fibrillation,” Texas Heart Institute Journal 31(3):257-265.Applicant
- Crystal, E. et al. (2003). “Left Atrial Appendage Occlusion Study (LAAOS): A Randomized Clinical Trial of Left Atrial Appendage Occlusion During Routine Coronary Artery Bypass Graft Surgery for Long-term Stroke Prevention,” Am Heart J 145(1):174-178.Applicant
- D'Avila, A. et al. (Apr. 2003). “Pericardial Anatomy for the Interventional Electrophysiologist,” Journal of Cardiovascular Electrophysiology 14(4):422-430.Applicant
- D'Avila, A. et al. (Nov. 2007). “Experimental Efficacy of Pericardial Instillation of Anti-inflammatory Agents During Percutaneous Epicardial Catheter Ablation to Prevent Postprocedure Pericarditis,” Journal of Cardiovascular Electrophysiology 18(11):1178-1183.Applicant
- Demaria, A.N. et al. (Dec. 17, 2003). “Highlights of the Year JACC 2003,” Journal of the American College of Cardiology 42(12):2156-2166.Applicant
- Deneu, S. et al. (Jul. 11, 1999). “Catheter Entrapment by Atrial Suture During Minimally Invasive Port-access Cardiac Surgery,” Canadian Journal of Anesthesia 46(10):983-986.Applicant
- Deponti, R. et al. (Mar. 7, 2006). “Trans-Septal Catheterization in the Electrophysiology Laboratory: Data From a Multicenter Survey Spanning 12 Years,” Journal of the American College of Cardiology 47(5):1037-1042.Applicant
- Donal, E. et al. (Sep. 2005). “The Left Atrial Appendage, a Small, Blind-Ended Structure: A Review of Its Echocardiographic Evaluation and Its Clinical Role,” Chest 128(3):1853-1862.Applicant
- Donnino, R. et al. (2007). “Left Atrial Appendage Thrombus Outside of a ‘Successful’ Ligation,” European Journal of Echocardiography pp. 1-2.Applicant
- Feinberg, W.M. et al. (Mar. 13, 1995). “Prevalence, Age Distribution, and Gender of Patients With Atrial Fibrillation,” Arch Intern Med 155:469-473.Applicant
- Fieguth, H.G. et al. (1997). “Inhibition of Atrial Fibrillation by Pulmonary Vein Isolation and Auricular Resection-Experimental Study in A Sheep Model,” European Journal of Cardio-Thoracic Surgery 11:714-721.Applicant
- Final Office Action mailed on Jun. 22, 2009, for U.S. Appl. No. 10/963,371, filed Oct. 11, 2004, 11 pages.Applicant
- Fisher, D.C. et al. (Dec. 1998). “Large Gradient Across a Partially Ligated Left Atrial Appendage,” Journal of the American Society of Echocardiography 11(12):1163-1165.Applicant
- Friberg, L. et al. (2006). “Stroke Prophylaxis in Atrial Fibrillation: Who Gets it and Who Does Not?” European Heart Journal 27:1954-1964.Applicant
- Friedman, P.A. et al. (Aug. 2009). “Percutaneous Epicardial Left Atrial Appendage Closure: Preliminary Results of an Electrogram Guided Approach,” Journal of Cardiovascular Electrophysiology 29(8):908-915.Applicant
- Fuster, V. et al. (2001). “ACC/AHA/ESC Guidelines for the Management of Patients with Atrial Fibrillation,” European Heart Journal 22:1852-1923.Applicant
- Garcia-Fernandez, M.A. et al. (Oct. 1, 2003). “Role of Left Atrial Appendage Obliteration in Stroke Reduction in Patients With Mitral Valve Prosthesis,” Journal of the American College of Cardiology 42(7):1253-1258.Applicant
- Gardiner, G.A. Jr. et al. (Apr. 1986). “Complications of Transluminal Angioplasty,” Radiology 159:201-208.Applicant
- Gillinov, A.M. (2007). “Advances in Surgical Treatment of Atrial Fibrillation,” Journal of the American Heart Association 38(part 2):618-623.Applicant
- Gilman, R.A. et al. (Apr. 1963). “Direct Left Ventricular Puncture,” California Medicine 98(4):200-203.Applicant
- Goodwin, W.E. et al. (Nov. 1950). “Translumbar Aortic Puncture and Retrograde Catheterization of the Aorta In Aortography and Renal Arteriography,” Annals of Surgery 132(5):944-958.Applicant
- Gottlieb, L.K. et al. (Sep. 12, 1994). “Anticoagulation in Atrial Fibrillation,” Arch Intern Med. 154:1945-1953.Applicant
- Graffigna, A. et al. (1993). “Surgical Treatment of Wolff-Parkinson-White Syndrome: Epicardial Approach Without the Use of Cardiopulmonary Bypass,” J. Card. Surg. 8:108-116.Applicant
- Haissaguerre, M. et al. (Nov. 2005). “Catheter Ablation of Long-Lasting Persistent Atrial Fibrillation: Clinical Outcome and Mechanisms of Subsequent Arrhythmias,” Journal of Cardiovascular Electrophysiology 16(11):1138-1147.Applicant
- Halperin, J.L. et al. (Aug. 1988). “Atrial Fibrillation and Stroke: New Ideas, Persisting Dilemmas,” Journal of the American Heart Association 19(8):937-941.Applicant
- Halperin, J.L. et al. (2003). “Obliteration of the Left Atrial Appendage for Prevention of Thromboembolism,” Journal of the American College of Cardiology 42(7):1259-1261.Applicant
- Hammill, S.C. (May 2006). “Epicardial Ablation: Reducing the Risks,” J. Cardiovasc. Electrophysiol. 17:550-552.Applicant
- Hara, H. et al. (Jan. 2008). “Percutaneous Left Atrial Appendage Obliteration,” JACC: Cardiovascular Imagin 1(1):92-93.Applicant
- Hart, R.G. et al. (1999) “Atrial Fibrillation and Thromboembolism: A Decade of Progress in Stroke Prevention,” Annals of Internal Medicine 131(9):688-695.Applicant
- Hart, R.G. et al. (Mar. 2001). “Atrial Fibrillation and Stroke: Concepts and Controversies,” Stroke 32:803-808.Applicant
- Hart, R.G. (Sep. 11, 2003). “Atrial fibrillation and Stroke Prevention,” The New England Journal of Medicine 349(11):1015-1016.Applicant
- Healey, J.S. et al. (Oct. 2003). “Surgical Closure of the Left Atrial Appendage for the Prevention of Stroke: A Randomized Pilot Trial of Safety and Efficacy (The Left Atrial Appendage Occlusion Study—LAAOS),” presented at The Canadian Cardiovascular Congress 2003, Toronot, Canada, Abstract No. 666, 2 pages.Applicant
- Healey, J.S. et al. (2005). “Left Atrial Appendage Occlusion Study (LAAOS): Results of a Randomized Controlled Pilot Study of Left Atrial Appendage Occlusion During Coronary Bypass Surgery in Patients At Risk for Stroke,” Surgery 150(2):288-293.Applicant
- Hein, R. et al. (2005). “Patent Foramen Ovale and Left Atrial Appendage: New Devices and Methods for Closure,” Pediatric Cardiology 26(3):234-240.Applicant
- Heist, E.K. et al. (Nov. 2006). “Analysis of the Left Atrial Appendage by Magnetic Resonance Angiography in Patients with Atrial Fibrillation,” Heart Rhythm 3(11):1313-1318.Applicant
- Ho, I. et al. (Apr. 24, 2007). “Percutaneous Epicardial Mapping Ablation of a Posteroseptal Accessory Pathway,” Circulation 115:418-421.Applicant
- Ho, S.Y. et al. (Nov. 1999). “Anatomy of the Left Atrium: Implications for Radiofrequency Ablation of Atrial Fibrillation,” Journal of Cardiovascular Electrophysiology 10(11):1525-1533.Applicant
- Hoit, B.D. et al. (Jan. 1993). “Altered Left Atrial Compliance After Atrial Appendectomy. Influence on Left Atrial and Ventricular Filling,” Circulation Research 72(1):167-175.Applicant
- Inoue, Y. et al. (Jul.-Aug. 1997). “Video Assisted Thoracoscopic and Cardioscopic Radiofrequency Maze Ablation,” Asaio Journal 43(4):334-337, Abstract Only.Applicant
- Jais, P. et al. (2003). “Radiofrequency Ablation for Atrial Fibrillation,” European Society of Cardiology 5(Supplement H):H34-H39.Applicant
- Johnson, W.D. et al. (2000). “The Left Atrial Appendage: Our Most Lethal Human Attachment! Surgical Implications,” Euro. J. Cardiothoracic. Surg. 17:718-722.Applicant
- Jongbloed, M.R.M. et al. (2005). “Clinical Applications of Intracardiac Echocardiography in Interventional Procedures,” Heart 91:981-990.Applicant
- Kamohara, K. et al. (2006). “Evaluation of a Novel Device for Left Atrial Appendage Exclusion: The Second-generation Atrial Exclusion Device,” The Journal of Thoracic and Cardiovascular Surgery 132(2):340-346.Applicant
- Kanderian, A.S. et al. (2008). “Success of Surgical Left Atrial Appendage Closure: Assessment by Transesophageal Echocardiography,” Journal of the American College of Cardiology 52(11):924-929.Applicant
- Kato, H. et al. (Aug. 1, 1996). “Evaluation of Left Atrial Appendage Stasis in Patients With Atrial Fibrillation Using Transesophageal Echocardiography With an Intravenous Albumin-Contrast Agent,” The American Journal of Cardiology 78:365-369.Applicant
- Katz, E.S. et al. (Aug. 2000). “Surgical Left Atrial Appendage Ligation is Frequently Incomplete: A Transesophageal Echocardiographic Study,” Journal of the American College of Cardiology 36(2):468-471.Applicant
- Kenner, H.M. et al. (Dec. 1966). “Intrapericardial, Intrapleural, and Intracardiac Pressures During Acute Heart Failure in Dogs Studied without Thoracotomy,” Circulation Research 19:1071-1079.Applicant
- Kerut, E.K. et al. (2008). “Anatomy of the Left Atrial Appendage,” Echocardiography 25(6):669-673.Applicant
- Khargi, K. et al. (2005). “Surgical Treatment of Atrial Fibrillation: A Systematic Review,” European Journal of Cardiothoracic Surgery 27:258-265.Applicant
- Kistler, P.M. et al. (May 2007). “The Left Atrial Appendage: Not Just an Innocent Bystander,” J. Cardiovasc Electrophysiol 18(5):465-466.Applicant
- Klein, H. et al. (Apr. 1990). “The Implantable Automatic Cardioverter-Defibrillator,” Herz 15(2):111-125, Abstract Only.Applicant
- Kolb, C. et al. (Feb. 2004). “Incidence of Antitachycardia Therapy Suspension Due to Magnet Reversion in Implantable Cardioverter Defibrillators,” Pace 27:221-223.Applicant
- Krikorian, J.G. et al. (Nov. 1978). “Pericardiocentesis,” Am. J. Med. 65(5):808-814.Applicant
- Krum, D. et al. (2004). “Visualization of Remnants of the left Atrial Appendage Following Epicardial Surgical Removal,” Heart Rhythm 1:249.Applicant
- Lacomis, J.M. et al. (Oct. 2003). “Multi-Detector Row CT of the Left Atrium and Pulmonary Veins before Radio-frequency Catheter Ablation for Atrial Fibrillation,” Radio Graphics 23:S35-S48.Applicant
- Lacomis, J.M. et al. (2007, e-pub. Oct. 17, 2007). “Dynamic Multidimensional Imaging of the Human Left Atrial Appendage,” Eurospace Advance Access 9:1134-1140.Applicant
- Lee, R. et al. (1999). “The Closed Heart MAZE: A Nonbypass Surgical Technique,” The Annals of Thoracic Surgery 67:1696-1702.Applicant
- Levinson, M.L. et al. (1998). “Minimally Invasive Atrial Septal Defect Closure Using the Subxyphoid Approach,” Heart Surg. Forum 1(1):49-53, Abstract Only.Applicant
- Lewis, D.R. et al. (1999). “Vascular Surgical Intervention for Complications of Cardiovascular Radiology: 13 Years' Experience in a Single Centre,” Ann. R. Coll. Surg. Engl. 81:23-26.Applicant
- Li, H. (Jan. 2007). “Magnet Decoration, Beautiful But Potentially Dangerous for Patients with Implantable Pacemakers or Defibrillators,” Heart Rhythm 4(1):5-6.Applicant
- Lindsay, B.D. (1996). “Obliteration of the Left Atrial Appendage: A Concept Worth Testing,” The Annals of Thoracic Surgery 51:515.Applicant
- Lip, G.Y.H. et al. (Jun. 2001). “Thromboprophylaxis for Atrial Flutter,” European Heart Journal 22(12):984-987.Applicant
- Lustgarten, D.L. et al. “Cryothermal Ablation: Mechanism of Tissue Injury and Current Experience in the Treatment of Tachyarrhythmias,” Progress in Cardiovascular Diseases 41(6):481-498.Applicant
- Maisch, B. et al. (Jan. 1999). “Intrapreicardial Treatment of Inflammatory and Neoplastic Pericarditis Guided by Pericardioscopy and Epicardial Biopsy-Results from a Pilot Study,” Clin. Cardiol. 22(Supp. I):I-17-I-22.Applicant
- Mannam, A.P. et al. (Apr. 1, 2002). “Safety of Subxyphoid Pericardial Access Using a Blunt-Tip Needle,” The American Journal of Cardiology 89:891-893.Applicant
- Mattox, K.L. et al. (May 1997). “Newer Diagnostic Measure and Emergency Management,” Ches Surg Clin N Am. 7(2):213-216, Abstract Only.Applicant
- McCarthy, P.M. et al. (2008). “Epicardial Atrial Fibrillation Ablation,” Chapter 23 in Contemporary Cardiology: Atrial Fibrillation, From Bench to Bedside, Natale, A. et al. eds., Humana Press,: Totowa, NJ, pp. 323-332.Applicant
- McCaughan, J.J. Jr., et al. (2009). “Aortography Utilizing Percutaneous Left Ventricular Puncture,” located at <http://www.archsurg.com>, last visited on Apr. 7, 2009, pp. 746-751.Applicant
- McClelland, R.R. (1978). “Congenital Aneurysmal Dilatation of the Left Auricle Demonstrated by Sequential Cardiac Blood-Pool Scintiscanning,” J. Nucl. Med. 19(5):507-509.Applicant
- Melo, J. et al. (Apr. 21, 2008). “Surgery for Atrial Fibrillation in Patients with Mitral Valve Disease: Results at Five Years from the International registry of Atrial Fibrillation Surgery,” The Journal of Thoracic and Cardiovascular Surgery 135(4):863-869.Applicant
- Miller, P.S.J. et al. (Feb. 2005). “Are Cost Benefits of Anticoagulation for Stroke Prevention in Atrial Fibrillation Underestimated?” Stroke 366:360-366.Applicant
- Miyasaka, Y. et al. (Jul. 11, 2006). “Secular Trends in Incidence of Atrial Fibrillation in Olmsted County. Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence,” Epidemiology 114:119-125.Applicant
- Mráz, T. et al. (Apr. 2007). “Role of Echocardiography in Percutaneous Occlusion of the left Atrial Appendage,” Echocardiography 24(4):401-404.Applicant
- Nakai, T. et al. (May 7, 2002). “Percutaneous Left Atrial Appendage Occlusion (PLAATO) for Preventing Cardioembolism: First Experience in Canine Model,” Circulation 105:2217-2222.Applicant
- Nakajima, H. et al. (2004). “Consequence of Atrial Fibrillation and the Risk of Embolism After Percutaneous Mitral Commissurotomy: The Necessity of the Maze Procedure,” The Annals of Thoracic Surgery 78:800-806.Applicant
- O'Donnell, M. et al. (2005). “Emerging Therapies for Stroke Prevention in Atrial Fibrillation,” European Heart Journal 7(Supplement C):C19-C27.Applicant
- Omran, H. et al. (1997). “Left Atrial Appendage Function in Patients with Atrial Flutter,” Heart 78:250-254.Applicant
- Onalan, O. et al. (2005). “Nonpharmacologic Stroke Prevention in Atrial Fibrillation,” Expert Rev. Cardiovasc. Ther. 3(4):619-633.Applicant
- Onalan, O. et al. (2007). “Left Atrial Appendage Exclusion for Stroke Prevention in Patients With Nonrheumatic Atrial Fibrillation,” Stroke 38(part 2):624-630.Applicant
- Ostermayer, S. et al. (2003). “Percutaneous Closure of the Left Atrial Appendage,” Journal of Interventional Cardiology 16(6):553-556.Applicant
- Ota, T. et al. (2006). “Epicardial Atrial Ablation Using a Novel Articulated Robotic Medical Probe Via a Percutaneous Subxiphoid Approach,” National Institute of Health 1(6):335-340.Applicant
- Ota, T. et al. (Oct. 2007). “Impact of Beating Heart left Atrial Ablation on Left-sided Heart Mechanics,” The Journal of Thoracic and Cardiovascular Surgery 134:982-988.Applicant
- Pennec, P-Y. et al. (2003). “Assessment of Different Procedures for Surgical Left Atrial Appendage Exclusion,” The Annals of Thoracic Surgery 76:2167-2168.Applicant
- Perk, G. et al. (Aug. 2009). “Use of Real Time Three-Dimensional Transesophageal Echocardiography in Intracardiac Catheter Based Interventions,” J. Am Soc Echocardiogr 22(8):865-882.Applicant
- Pollick C. (Feb. 2000). “Left Atrial Appendage Myopathy,” Chest 117(2):297-308.Applicant
- Poulsen, T.S. et al. (Feb. 15, 2005). “Is Aspirin Resistance or Female Gender Associated With a High Incidence of Myonecrosis After Nonurgent Percutaneous Coronary Intervention?” J. Am. Coll. Cardiol. 45(4):635-636.Applicant
- Reznik, G. et al. (Oct. 1992). “Percutaneous Endoscopic Implantation of Automatic Implantable Cardioverter/Defibrillator (AICD): An Animal Study of a New Nonthoracotomy Technique,” J. Laparoendosc. Surg. 2(5):255-261, Abstract Only.Applicant
- Robicsek, F. (1987). “Closed-Chest Decannulation of Transthoracically Inserted Aortic Balloon Catheter without Grafting,” Journal of Cardiac Surgery 2(2):327-329.Applicant
- Ross, J. Jr. et al. (Jun. 3, 2008). “Transseptal Left Heart Catheterization: a 50-Year Odyssey,” Journal of the American College of Cardiology 51(22):2107-2115.Applicant
- Rubin, D.N. et al. (Oct. 1, 1996). “Evaluation of Left Atrial Appendage Anatomy and Function in Recent-Onset Atrial Fibrillation by Transesophageal Echocardiography,” Am J Cardiol 78:774-778.Applicant
- Ruchat, P. et al. (2002). “Off-pump Epicardial Compartmentalization for Ablation of Atrial Fibrillation,” Interactive Cardio Vascular and Thoracic Surgery 1:55-57.Applicant
- Salzberg, S.P. et al. (2008). “Surgical Left Atrial Appendage Occlusion: Evaluation of a Novel Device with Magnetic Resonance Imaging,” European Journal of Cardiothoracic Surgery 34:766-770.Applicant
- Sapp, J. et al. (Dec. 2001). “Electrophysiology and Anatomic Characterization of an Epicardial Accessory Pathway,” Journal of Cardiovascular Electrophysiology 12(12):1411-1414.Applicant
- Scharf, C. et al. (2005). “Catheter Ablation for Atrial Fibrillation: Pathophysiology, Techniques, Results and Current Indications,” Continuous Medical Education 8:53-61.Applicant
- Scherr, D. et al. (Apr. 2009). “Incidence and Predictors of left Atrial Thrombus Prior to Catheter Ablation of Atrial Fibrillation,” Journal of Cardiovascular Electrophysiology 20(4):379-384.Applicant
- Schmidt, H. et al. (2001). “Prevalence of Left Atrial Chamber and Appendage Thrombi in Patients With Atrial Flutter and Its Clinical Significance,” Journal of the American College of Cardiology 38(3):778-784.Applicant
- Schneider, B. et al. (2005). “Surgical Closure of the Left Atrial Appendage—A Beneficial Procedure?” Cardiology 104:124-132.Applicant
- Schweikert, R.A. et al. (Sep. 16, 2003). “Percutaneous Pericardial Instrumentation for Endo-Epicardial Mapping of Previously Failed Ablation,” Circulation 108:1329-1335.Applicant
- Schweikert, R.A. et al. (2005). “Epicardial Access: Present and Future Applications for Interventional Electrophysiologists,” Chapter 25 in New Arrhythmia Technolgies, Wang, P.J. ed., Blackwell Publishing, pp. 242-256.Applicant
- Sengupta, P.P. et al. (2005). “Transoesophageal Echocardiography,” Heart 91:541-547.Applicant
- Sharada, K. et al. (2005). “Non-Surgical Transpericardial Catheter Ablation of Post-Infarction Ventricular Tachycardia,” Indian Heart J 57:58-61.Applicant
- Sievert, H. et al. (Apr. 23, 2002). “Percutaneous Left Atrial Appendage Transcatheter Occlusion to Prevent Stroke in High-Risk Patients With Atrial Fibrillation,” Circulation 105:1887-1889.Applicant
- Singer, D.E. et al. (Sep. 2004). “Antithrombotic Therapy in Atrial Fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy,” Chest 126(3):429-456.Applicant
- Smith, P.W. (Nov. 1956). “Diagnosis of Mitral Regurgitation by Cardioangiography,” Circulation 14:847-853.Applicant
- Soejima, K. et al. (2004). “Subxiphoid Surgical Approach for Epicardial Catheter-Based Mapping and Ablation in Patients With Prior Cardiac Surgery or Difficult Pericardial Access,” Circulation 110:1197-1201.Applicant
- Sosa, E. et al. (Jul. 15, 2002). “Gaining Access to the Pericardial Space,” The American Journal of Cardiology 90:2003-2004.Applicant
- Sosa, E. et al. (Apr. 2005). “Epicardial Mapping and Ablation Techniques to Control Centricular Tachycardia,” Techniques and Technology 16(4):449-452.Applicant
- Sparks, P.B. et al. (2001). “Is Atrial Flutter a Risk Factor for Stroke?” Journal of the American College of Cardiology 38(3):785-788.Applicant
- Spodick, D.H. (Nov. 1970). “Medical History of the Pericardium,” The American Journal of Cardiology 26:447-454.Applicant
- Stewart, J.M. et al. (Apr. 1992). “Bilateral Atrial Appendectomy Abolishes Increased Plasma Atrial Natriuretic Peptide Release and Blunts Sodium and Water Excretion During Volume Loading in Conscious Dogs,” Circulation Research 70(4):724-732.Applicant
- Stoddard, M.F. et al. (1995). “Left Atrial Appendage Thrombus is not Uncommon in Patients with Acute Atrial Fibrillation and a Recent Embolic Event: A Transesophageal Echocardiographic Study,” J. Am. Coll. Cardiol. 25:452-459, Abstract Only.Applicant
- Stollberger, C. et al. (2000). “Is the Left Atrial Appendage Our Most Lethal Attachment?” European Journal of Cardio-Thoracic Surgery 18:625-626.Applicant
- Stollberger, C. et al. (Dec. 2003). “Elimination of the Left Atrial Appendage To Prevent Stroke or Embolism?: Anatomic, Physiologic, and Pathophysiologic Considerations,” 124(6):2356-2362.Applicant
- Stollberger, C. et al. (2006). “Stroke Prevention by Means of Epicardial Occlusion of the Left Atrial Appendage,” Journal of Thoracic and Cardiovascular Surgery 132(1):207-208.Applicant
- Stollberger, C. et al. (2007). “Arguments Against Left Atrial Appendage occlusion for Stroke Prevention,” Stroke 38: 1 page.Applicant
- Stollberger, C. et al. (2007). “Leave the Left Atrial Appendage Untouched for Stroke Prevention!” Journal of Thoracic and Cardiovascular Surgery 134(2):549-550.Applicant
- Su, P. et al. (Sep. 2008, e-pub. May 8, 2007). “Occluding the Left Atrial Appendage: Anatomical Considerations,” Heart 94(9):1166-1170.Applicant
- Subramanian, V.A. (Jun. 1997). “Less Invasive Arterial CABG on a Beating Heart,” Ann. Thorac. Surg. 63(6 Suppl.):S68-S71.Applicant
- Subramanian, V.A. et al. (Dec. 1997). “Minimally Invasive Direct Coronary Artery Bypass Grafting: two-Year Clinical Experience,” Ann. Thorac. Surg. 64(6):1648-1653, Abstract Only.Applicant
- Sun, F. et al. (Feb. 2006). “Subxiphoid Access to Normal Pericardium with Micropuncture Set: Technical Feasibility Study in Pigs,” Radiology 238(2):719-724.Applicant
- Szili-Torok, T. et al. (2001). “Transseptal Left heart Catheterisation Guided by Intracardiac Echocardiography,” Heart 86:e11-e15.Applicant
- Tabata, T. et al. (Feb. 1, 2998). “Role of Left Atrial Appendage in left Atrial Reservoir Function as Evaluated by Left Atrial Appendage Clamping During Cardiac Surgery,” The American Journal of Cardiology 81:327-332.Applicant
- Tomar, M. et al. (Jul.-Aug. 2006). “Transcatheter Closure of Fossa Ovalis Atrial Septal Defect: A Single Institutional Experience,” Indian Heart Journal 58(4):325-329.Applicant
- Troughton, R.W. et al. (Feb. 28, 2004). “Pericarditis,” The Lancet 363:717-727.Applicant
- Ulicny K.S. et al. (Jun. 1992). “Conjoined Subrectus Pocket for Permanent Pacemaker Placement in the Neonate,” Ann Thorac Surg. 53(6):1130-1131, Abstract Only.Applicant
- Valderrabano, M. et al. (Sep. 2004). “Percutaneous Epicardial Mapping During Ablation of Difficult Accessory Pathways as an Alternative to Cardiac Surgery,” Heart Rhythm 1(3):311-316.Applicant
- Von Korn, H. et al. (2006). “Simultaneous Combined Interventional Percutaneous Left Atrial Auricle and Atrial Septal Defect Closure,” Heart 92:1462.Applicant
- Wang, T.J. et al. (Aug. 27, 2003). “A Risk Score for Predicting Stroke or Death in Individuals With new-Onset Atrial Fibrillation in the Community,” American Medical Association 290(8):1049-1056.Applicant
- W.L. Gore & Associates (Aug. 11, 2006). “Gore Helex™ Septal Occluder,” located at <http://www.fda.gov/cdrh/pdf5/p050006a.pdf>, last visited on Jun. 14, 2007, 3 pages.Applicant
- Wolber, T. et al. (Jan. 2007). “Potential Interference of Small Neodymium Magnets with Cardiac pacemakers and Implantable Cardioverter-defibrillators,” Heart Rhythm 4(1):1-4.Applicant
- Wolf, P.A. et al. (Oct. 1978). “Epidemiologic Assessment of Chronic Atrial Fibrillation and Risk of Stroke: The Fiamingham Study,” Neurology 28:973-977.Applicant
- Wolf, P.A. et al. (1991). “Atrial Fibrillation as an Independent Risk Factor for Stroke: The Framingham Study,” Journal of the American Heart Association 22(8):983-988.Applicant
- Wolf, P.A. et al. (Feb. 9, 1998). “Impact of Atrial Fibrillation on Mortality, Stroke, and Medical Costs,” Arch Intern Med 158:229-234.Applicant
- Wong, J.W.W. et al. (2006). “Impact of Maze and Concomitant Mitral Valve Surgery on Clinical Outcomes,” The Annals of Thoracic Surgery 82:1938-1947.Applicant
- Wongcharoen, W. et al. (Sep. 2006). “Morphologic Characteristics of the Left Atrial Appendage, Roof, and Septum: Implications for the Ablation of Atrial Fibrillation,” Journal of Cardiovascular Electrophysiology 17(9):951-956.Applicant
- Wood, M.A. (Jan. 2006). “Percutaneous Pericardial Instrumentation in the Electrophysiology Laboratory: A Case of Need,” Heart Rhythm 3(1):11-12.Applicant
- Wudel, J.H. et al. (Apr. 3, 2008). “Video-Assisted Epicardial Ablation and left Atrial Appendage Exclusion for Atrial Fibrillation: Extended Follow-Up,” The Annals of Thoracic Surgery 85:34-38.Applicant
- Wyse, D.G. et al. (Dec. 5, 2002). “Of ‘Left Atrial Appendage Amputation, Ligation, or Occlusion in Patients with Atrial Fibrillation',” N Engl J Med 347(23):1825-1833, Abstract Only.Applicant
- Yamada, Y. et al. (Aug. 2006). “Video-Assisted Thoracoscopy to Treat Atrial Tachycardia Arising from Left Atrial Appendage,” Journal of Cardiovascular Electrophysiology 17(8):895-898.Applicant
- Zapolanski, A. et al. (May 2008). “Safe and Complete Exclusion of the left Atrial Appendage, A Simple Epicardial Approach,” Innovations 3(3):161-163.Applicant
- Zenati, M.A. et al. (Sep. 2003). “Left Heart Pacing Lead Implantation Using Subxiphoid Videopericardioscopy,” Journal of Cariodvascular Electrophysiology 14(9):949-953.Applicant
- Zenati, M.A. et al. (2004). “Mechanical Function of the Left Atrial Appendage Following Epicardial Bipolar Radiofrequency Ablation,” Cardiothoracic Techniques and Technologies X, Abstract 121A, p. 176.Applicant
- Zenati, M.A. et al. (2005). “Modification of the Left Atrial Appendage,” Chapter 12 in Innovative Mangement of Atrial Fibrillation, Schwatzman, David ed., Blackwell Science Ltd., 5 pages.Applicant
- Final Office Action mailed on Jul. 21, 2010, for U.S. Appl. No. 11/400,714, filed on Apr. 7, 2006, 10 pages.Applicant
- Non-Final Office Action mailed on Dec. 30, 2009, for U.S. Appl. No. 11/400,714, filed on Apr. 7, 2006, 8 pages.Applicant
- Non-Final Office Action mailed on Jul. 22, 2010, for U.S. Appl. No. 12/037,802, filed on Feb. 26, 2008, 10 pages.Applicant